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Abstract (deutsch) 
 
Der einzellige, humanpathogene Parasit Trichomonas vaginalis ist der Erreger der 
Trichomonose, die mit rund 170 Millionen Neuinfektionen pro Jahr die weltweit 
häufigste nicht-virale Geschlechtskrankheit darstellt. Die Trichomonose ist zwar nicht 
primär lebensbedrohlich, ist aber eine sehr unangenehme Infektion und kann 
mitunter auch schwer verlaufen. Chronische Infektionen gelten als Risikofaktor für 
verschiedene Krebserkrankungen und begünstigen eine HIV-Infektion. Im Falle einer 
Schwangerschaft führen sie meist zu einer Frühgeburt und niedrigem 
Geburtsgewicht. Zur Behandlung der Trichomonose wird seit nunmehr 50 Jahren 
Metronidazol eingesetzt. Dieses zu den Nitroimidazolen zählende Antibiotikum wird 
oral verabreicht und im Allgemeinen auch gut vertragen, hat jedoch zum Teil schwere 
Nebenwirkungen und ist für Schwangere wegen seiner Plazentagängigkeit 
ungeeignet. Außerdem führt die wachsende Zahl an Metronidazol-resistenten 
Trichomonaden-Stämmen immer wieder zu Therapieversagen. Bisher steht 
allerdings kein gutes Alternativpräparat zur Behandlung der Trichomonose zur 
Verfügung.  
 
Pentamycin, ein Antimykotikum, das zu den Polyenen zählt, wurde bislang 
hauptsächlich gegen Infektionen mit Candida-Pilzen angewendet, erwies sich 
allerdings in Vorversuchen auch als wirksam gegen Trichomonaden.  
 
Das Ziel der vorliegenden Arbeit war die genaue Untersuchung der Wirksamkeit von 
Pentamycin gegen T. vaginalis. Hierzu wurden sowohl die inkubationszeit- und 
dosisabhängige Effektivität von Pentamycin gegen vier unterschiedlich Metronidazol-
sensitive Stämme als auch die Zusammensetzung des Proteoms vor und nach der 
ABSTRACTS 
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Behandlung untersucht. Außerdem wurde über einen Zeitraum von sechs Monaten 
die Ausbildung von Resistenzen überwacht. 
 
Es konnte gezeigt werden, dass Pentamycin außerordentlich effektiv gegen T. 
vaginalis ist. Eine hundertprozentige Abtötung der Trichomonaden wurde bereits mit 
einer Konzentration von 15 µg/ml und einer Behandlungsdauer von 1h erreicht. Alle 
vier Trichomonas-Stämme zeigten eine annähernd gleiche Sensitivität. Die mittels 
SDS-PAGE analysierten Proteinprofile sprechen dafür, dass die Wirkung von 
Pentamycin auf einer Schädigung der Zellmembran beruht, die in weiterer Folge zu 
einer totalen Lyse der Trichomonaden führt. Die vier untersuchten T. vaginalis-
Stämme haben auch nach sechsmonatiger Dauerbehandlung mit niedrigen Dosen 
von Pentamycin keine Resistenzen ausgebildet, es konnte allerdings ein reversibler 
Gewöhnungseffekt beobachtet werden. Ebenso konnte eine Kreuzresistenz mit dem 
verwandten Antibiotikum Amphotericin B, das vor allem gegen Leishmanien 
angewendet wird, ausgeschlossen werden; allerdings war ein synergistischer Effekt 
bei gleichzeitiger Anwendung beider Wirkstoffe feststellbar. 
 
Die Ergebnisse dieser Studie sprechen für eine hohe Wirksamkeit von Pentamycin 
gegenüber T. vaginalis, besonders vielversprechend ist das gute Ansprechen von 
Metronidazol-resistenten Stämmen auf die Behandlung. 
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Abstract (english) 
 
The protozoan parasite Trichomonas vaginalis is the causative agent of trichomono- 
sis which is – with more than 170 million new cases each year – the most prevalent 
non-viral sexually transmitted disease (STD) worldwide. Although trichomonosis is 
not a primarily lethal disease, the clinical picture can include severe urogenital 
inflammations. Chronic infections have been associated with cervical/prostate cancer 
and a predisposition of HIV infections. In case of pregnancy, chronic infections can 
also lead to preterm delivery and low birth weight. For more than 50 years, 
metronidazole, a nitroimidazole antibiotic, has been in use for the treatment of 
trichomonosis. It is applied orally and although it is mostly compliant, it can have 
serious side effects. It is also not applicable for pregnant women due to its ability to 
pass the placenta. Furthermore, an increasing number of emerging metronidazole-
resistant T. vaginalis strains has lead to more treatment failures in the last few years. 
To this day, however, there is no effective alternative drug against trichomonosis 
available.  
 
Pentamycin is a polyene antimycotic and has been in use in the treatment of 
candidiasis, in preliminary studies it also turned out to be effective against 
trichomonads.  
 
The aim of this study was to evaluate the efficacy of pentamycin against T. vaginalis 
and the ability to develop resistances in vitro. For these purposes, the dose-effect 
relationship between pentamycin and four differently metronidazole-sensitive T. 
vaginalis strains was investigated. Moreover, the protein composition before and after 
the treatment was compared. To induce resistance, strains were treated with 
sublethal concentrations of pentamycin within a time of six months.  
ABSTRACTS 
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It could be shown that pentamycin is highly effective against T. vaginalis. A 100% 
eradication of trichomonads was reached with a concentration of 15 µg/ml and an 
incubation time of 1h. All four differently metronidazole-sensitive strains showed 
almost the same sensitivity to pentamycin. The comparison of the protein profiles of 
untreated and treated cells analysed by SDS-PAGE showed that the mode of action 
of pentamycin is based on an interaction and subsequent damage of the cell 
membrane which consequently leads to total lysis and death of the cell. After six 
months of long-term treatment, no establishment of resistance but a partial, 
reversible adaptation to low doses was recordable. Moreover, T. vaginalis did not 
express cross resistance to amphotericin B – a pentamycin related polyene antibiotic 
that is mostly applied against leishmaniosis – but both drugs acted synergistically 
when administered simultaneously.  
 
The results of this study confirm the high efficacy of pentamycin against T. vaginalis, 
and particuarly the susceptibility of metronidazole-resistant strains to pentamycin is 
promising. 
 
 
 
 
 
 
 INTRODUCTION 
 
10 
1 Introduction 
 
This diploma thesis deals with the unicellular human parasite Trichomonas vaginalis, 
the disease caused by it, the treatment with metronidazole, and, which is the main 
part of the thesis, the investigation of the effect of the polyene drug pentamycin on T. 
vaginalis. 
 
1.1   Trichomonads 
 
1.1.1 Parasitism and protozoa 
 
The term “parasitology” is defined as the work with parasites, parasitism and 
parasitoses. The word “parasite” has its origin in Greek (“para” for besides, next to; 
“sitos” for eating). Originally it described people who participated in sacrificial feasts 
by tasting the slaughtered animals to avoid food poisoning. This was an honourable 
occupation and did not have any negative meaning yet. The term later received 
negative connotation when rich people invited such parasites not only to eat with 
them but also to entertain them, whereupon the parasites became dependent on their 
hosts. So the understanding of a parasite became established as someone who lives 
at the expense of someone else (HIEPE, 2006). 
 
In the biological-medical context a parasite is defined as an organism that lives 
obligatorily or temporarily in or on a foreign, usually larger organism (host), harming it 
as a consequence of depriving life energy for its benefit but without killing it. In the 
narrower context it defines exclusively organisms that belong to the arthropods, 
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helminths, or protozoans, of these only the arthropods representing a true phylum 
(ASPÖCK & WALOCHNIK, 2002; DEPLAZES & ECKERT, 2005). 
 
The term “protozoa” has been introduced by the German biologist Georg August 
GOLDFUSS in 1818 from the Greek (“proto” for first; “zoa” for animals) and was 
considered as a term for a discrete and monophyletic systematic group for a long 
time, although it comprises a variety of organisms that are not really related to each 
other. Today the term is used as a collective for unicellular, heterotrophic eukaryotes 
without a cell wall and is only based on morphological characteristics (HEMPHILL & 
GOTTSTEIN, 2006). 
 
 
1.1.2  Research history 
 
The first isolation of trichomonads, which were classified as Trichomonas tenax by 
Clifford DOBELL later in 1939, was achieved in the year 1773 by the Danish scientist 
Otho Fridericus MÜLLER. 63 years later, in 1836, Alfred DONNÉ succeeded in the first 
isolation of T. vaginalis. He named it Trichomonas as he believed to recognize 
properties of the two protozoa Tricodes and Monas, and vaginalis because he had 
found it in a woman suffering from vaginitis. Nevertheless, he mentioned that the 
organism can occur in the genital secretion of both women and men. Around the turn 
of the 19th to the 20th century, Ernst HAECKEL published the classic “Kunstformen der 
Natur”, in which he precisely described the morphology of Trichomonas and painted it 
on page 13, figure 4 (Fig.1). He named it Trichomonas intestinalis because he 
observed mainly Trichomonas species living in the intestines of vertebrates (ACKERS, 
2001; WALOCHNIK & ASPÖCK, 2002). 
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In the 1880s, Otto BÜTSCHLI (1848-1920), a German zoologist who is honoured as the 
“architect of protozoology”, published the standard work “Protozoa” which has been 
released in three editions and stands out as a very precise description of families and 
genera of trichomonads. Moreover, BÜTSCHLI tried to understand the evolution of 
eukaryotic cells and to relate the different groups. So he created the term 
“undulipodia” which is not correct regarding to systematics but should clarify the 
common origin of evolution between pseudopodia and flagellata (BÜTSCHLI, 1880–
1889). 
 
From the date of DONNÉ’S discovery, T. vaginalis was not considered as a human 
pathogenic organism until 1916, when HÖHNE proved it to be the causative agent in 
some cases of vaginitis (HÖHNE, 1916). As recently as in 1978, this concept became 
universally accepted by the work of HONIGBERG (HONIGBERG, 1978).  
 
The invention of the electronic microscope around 1940 revolutionized the field of 
biological sciences and allowed the elucidation of small cellular compartments due to 
its higher resolution compared to light microscopy. The anatomy of eukaryotic flagella 
was discovered and described as well as the existence of the hydrogenosomes, 
organella for anaerobic metabolism and characteristic for trichomonads (WALOCHNIK 
& ASPÖCK, 2002). 
 
Before the discovery of metronidazole, the human veneral disease caused by 
Trichomonas vaginalis was treated with natural remedies like garlic, cranberries and 
other red berries in naturopathy – today some authors still believe in that way of 
treatment – (HEMERKA, 2008) and typically with substances like acetarsol, trichomycin 
and potassium iodide in orthodox medicine, which may have relieved the symptoms 
but did not cure the disease as they are unable to take effect in the genitourinary 
 INTRODUCTION 
 
13 
region (DUREL et al., 1960). In 1959, the 5-nitro-imidazole drug metronidazole was 
introduced for treatment of trichomonosis and it has been the standard drug until 
now, although metronidazole-resistant trichomonads were already discovered and 
described in 1979 (COSAR & JULOU, 1959; KULDA, 1999). 
 
 
Fig.1: Trichomonas intestinalis from Ernst HAECKEL, Kunstformen der Natur;  
page 13, fig. 4: Die Geißelthierchen. 
 
 
1.1.3   Systematics and evolution  
 
Ernst HAECKEL, the man who made Darwin’s theory of evolution popular, did not only 
describe the morphological properties of trichomonads very precisely, he also 
established a phylogenetic system in which he classified the trichomonads as 
members of the phylum Protozoa, the order of the Infusoria and the class of the 
Flagellata. The taxon Flagellata had already been established in 1853 by COHN for 
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unicellular organisms (including also bacteria) with one or more flagella. Later, Otto 
BÜTSCHLI added the criterion that these organisms have flagella only in the main 
stage of their life cycle. So it was possible to distinguish between “real flagellates” 
and “unreal flagellates” like gametes (WALOCHNIK & ASPÖCK, 2002). 
 
This system was later replaced by a more precise but still morphology-based one that 
divided the eukaryotes into the Protozoa and the Metazoa, the Protozoa including six 
groups: the Flagellata, the Rhizopodia, the Sporozoa, the Microspora, the Myxozoa 
and the Ciliata. Amongst six other orders, the order Trichomonidida belonged to the 
class of the Flagellates (STORCH & WELSCH, 1997).  
 
This widely used classification system was more or less kept up until 2005. Currently, 
the most widely accepted classification scheme is the one by ADL et al., who 
classified the kingdom of the eukaryotes into six supergroups: The Amoebozoa 
(Tubulinea, Flabellinaea, Stereomyxida, Acanthamoebidae, Entamoebida, 
Mastigamoebida, Pelomyxa and Eumycetozoa), the Opisthokonta (Fungi, 
Mesomycetozoa, Chonomonada, and Metazoa, including all multi-cellular animals), 
the Rhizaria (Cercozoa, Haplosporidia, Foraminifera, Gromia and Radiolaria), the 
Archaeplastida (Glaucophyta, Rhodophyceae and Chloroplastida, including the 
foliage plants), the Chromalveolata (Cryptophyceae, Haptophyta, Stramenopyles and 
Alveolata) and the Excavata (Fornicata, Malawimonas, Parabasala, Praexostylata, 
Jakobida, Heterolobosea and Euglenozoa) (Tab.1). In this system, Trichomonas 
vaginalis is one of four species of the genus Trichomonas in the family 
Trichomonadida and the order Trichomonadidae. Further families are 
Calonymphidae, Cochlosomatidae, Devescovinidae and Monocercomonadidae, 
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which all belong to the group of the Parabasalia within the Excavata supergroup (ADL 
et al., 2005). 
A characteristic of the Excavata is their cytostome, a sort of mouth. Additionally their 
subgroup – the Parabasalids – is characterised by an anaerobic metabolism, lack of 
mitochondria, amoeboid-like cell surface and complex microtubule structures. They 
can exist only in a community with animals, whether by symbiosis, commensalism, or 
parasitism, like T. vaginalis (CAVALIER-SMITH, 2002).  
 
As Trichomonas – as well as diplomonads, microsporidians and Entamoeba – do not 
possess mitochondria, they have special organella, the so-called hydrogenosomes, 
for their anaerobic metabolism. Initially, it was thought that eukaryotes without 
mitochondria are primitive and had already developed before endosymbiotic bacteria 
led to the evolution of mitochondria. In the 1980s, CAVALIER-SMITH created a new 
term for this group, the Archezoa, including diplomonads, microsporidians and 
trichomonads, but not Entamoeba due to their higher evolutionary level. This has led 
to a theory of secondary loss of mitochondria (CAVALIER-SMITH, 1987; TOVAR et al., 
1999).      
 
Later, in 1998, CAVALIER-SMITH published “A revised six-kingdom system of life”, in 
which he divided the kingdom Archezoa into two phyla, the Metamonada, including 
Giardia and Chylomastix, and the Trichozoa. The Trichozoa were divided further into 
the Anaeromonada, including Trimastix, and the Parabasala, including the families 
Trichomonadida and Trichonympha (CAVALIER-SMITH, 1998).  
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Tab. 1: Systematic table of the eukaryotes, modified after ADL et al., 2005. 
 
 EUKARYA  
 
   
Opisthokonta 
 
 
 
 
 
 
 
Fungi 
Mesomycetozoa 
Chonomonada 
Metazoa 
  
Asterias rubens (Metazoa) 
(Photo: Original) 
 
 
Amoebozoa 
 
Flabellinea 
Stereomyxida 
Acanthamoebidae 
Entamoebida 
Mastigamoebida 
Pelomyxa 
Eumycetozoa 
 
 
Acanthamoeba astronyxis (Acanthamoebidae) 
(Photo from PAGE, 1991) 
 
 
Rhizaria 
 
 
Cercozoa 
Haplosporidia 
Foraminifera 
Gromia 
Radiolaria  
Ammonia tepida (Foraminifera) 
(Photo: From English Wikipedia. Original description: 
Live Ammonia tepida benthic foraminiferan collected from 
San Francisco Bay. Phase-contrast photomicrograph by 
Scott Fay, UC Berkeley, 2005) 
 
 
 
Archae- 
plastida 
 
 
Glaucophyta 
Rhodophyceae 
Chloroplastida 
 
 
Pinus pinea (Chloroplastida) 
(Photo: Original) 
 
 
 
Chrom- 
alveolata 
 
 
Chryptophyceae 
Haptophyta 
Stramenopyles 
Alveolata 
 
 
Plasmodium falciparum (Alveolata) 
(Photo from Astelbauer, 2010) 
 
 
 
Excavata 
 
Formicata 
Malawimonas 
Parabasala 
Praexostylata 
Jakobida 
Heterolobosea 
Euglenozoa 
 
Trichomonas vaginalis (Parabasala) 
(Photo: M. Syrowatka, Giemsa stained) 
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However, more recent molecularbiological studies have shown that trichomonads as 
well as the other members of the Archezoa primarily did have mitochondria but either 
lost them by adaptation to their anaerobic mode of life, as in diplomonads and 
microsporidians, or were converted to hydrogenosomes, as in trichomonads (EMBLEY 
et al., 2003). Also, genes that seem to have a mitochondrial origin were found in their 
nuclei. These genes code for adenylate kinase, heat-shock proteins 10, 60, and 70 
kDa, triosephosphate isomerase, and the valyl-tRNA synthetase (EMBLEY & HIRT, 
1998). Because organisms with mitochondria possess genes that were transferred 
from mitochondria into the nucleus during the evolution (“numts”), this concedes the 
case that the mitochondrial genes of trichomonads have their origin in true 
mitochondria (LOPEZ et al., 1994). Nevertheless, trichomonads seem to have 
diverged from the eukaryotic tree of life very early. This theory is supported by many 
molecular biological studies and 18S rRNA analyses that have also shown that the 
Trichomonadida are a monophyletic lineage and represent a deep branch of the 
eukaryotic evolutionary tree (GUNDERSON et al., 1995). Apparently, the lack of 
mitochondria does not mean an ancestral role in the tree of life implicitly, but may be 
a result of adaptations to environment. Data from phylogenetical analyses of fungi 
and ciliates possessing hydrogenosomes and lacking mitochondria have also proved 
that these organella must have evolved from mitochondria and also many times 
amongst the eukaryotes (EMBLEY et al., 2003). 
 
Further molecular biological and phylogenetical studies have confirmed that the 
family of the Trichomonadidae represents a monophyletic group (DELGADO-
VISCOGLIOSI et al., 2000). Even all investigated strains within the species 
Trichomonas vaginalis are monophyletic although there are some differences in their 
metabolism. Nevertheless, or even for this reason, there is a positive correlation 
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between the degree of relationship and the susceptibility to metronidazole. On the 
other hand, the relationship does not correlate with virulence or geographic origin 
(HAMPL et al., 2001). 
 
18S rRNA analyses indicate that the radiation of the recent trichomonadiae occurred 
rather recently in the history of Earth, maybe in connection with the radiation of their 
animal hosts which are mostly mammals and birds (GUNDERSON et al., 1995).  
A recent study assumes that even dinosaurs may have had trichomonads, which 
could have harmed them severely. In 2009, scientists found out that lesions in the 
jaw bones of a Tyrannosaurus rex had been caused by trichomonads. These 
infections might have led to starvation as the dinosaur could not move its jaws 
anymore. Interestingly, these trichomonads are closely related to recent Trichomonas 
galinae that are specialised on birds and can harm them profoundly in a similar way. 
This does not only show that trichomonads have existed before their current hosts 
but also supports the relationship between dinosaurs and birds on the level of their 
parasites (WOLFF et al., 2009). 
 
There are still some inclaritites regarding the role of Trichomonas in the tree of life. 
The early branching of Trichomonas and also Giardia in 18S rRNA trees can also be 
explained by the “long branch attraction”, which says that long branches always form 
a group, neglecting the phylogenetic relationship. So these two groups could also 
have developed simultaneously with all other eukaryonts. Moreover, analyses of 
RBP1 as well as EF-1∝ and EF-2 could not confirm an early diverging of 
Trichomonas and Giardia. The “hydrogen hypothesis”, a theory that supports a sister 
group relationship between Trichomonas and Giardia, assumes that proteobacteria 
became incorporated first by an archaebacterium, evolving to mitochondria later, or 
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to hydrogenosomes in anaerobians, respectively. A relationship between 
Trichomonas and Giardia would also support the theory of modified mitochondria 
(Trichomonas) and secondary loss of mitochondria (Giardia) (EMBLEY & HIRT, 1998). 
 
 
1.1.3 The Trichomonadea  
 
Tab. 2 shows the phylogenetic position of T. vaginalis. Basing on recent 
ultrastructural and molecular phylogenetic studies, the parabasalids consist of six 
main lineages at the rank of a class: Hypotrichomonadea, Trichomonadea, 
Tritrichomonadea, Cristamonadea, Trichononymphea, and Spirotrichonymphea. The 
presence of a single mastigont with 2–6 flagella and the absence of a comb-like 
structure as well as an infrakinetosomal body are characteristic for the 
Trichomonadea. The class of the Trichomonadea is dividided into two orders which 
are monophyletic: Trichomonadida, containing the family Trichomonadidae (with a 
costa), and Honigbergiellida, containing the families Honigbergiellidae, 
Hexamastigidae, and Tricercomitidae (without a costa). 
 
The order Trichomonadida is further subdivided into the family Trichomonadidae 
which splits into two groups: The Trichomonas group and the Pentatrichomonas 
group. Within the Trichomonas group, four genera branch: Trichomonas, 
Trichomonoides, Tetratrichomonas, and Pentatrichomonas. Representatives of 
Trichomonas colonize the urogenital tract, intestine, and oral cavity of birds and 
mammals and comprise some true pathogens (CEPICKA et al., 2010):  
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Tab. 2: Classification of Trichomonas vaginalis (after CEPCICKA et al., 2010). 
Domain Eukarya 
Kingdom Excavata 
Phylum Parabasalia 
Class Trichomonadea 
Order Trichomonadidae 
Family Trichomonadida 
Genus Trichomonas 
Species Trichomonas vaginalis 
 
Trichomonas galinae parasitizes birds, especially pigeons, and can lead to severe 
decimations in the populations. The trichomonads colonize the mucosa of the 
pharynx, the oesophagus and the struma, causing yellow accretions that disable 
ingestion and lead to starvation (ROBINSON et al., 2010).  
 
Trichomonas tenax, sometimes also referred to as T. buccalis or T. elongata, 
colonizes the oral cavity, especially the enamel and gingival, and feeds on the 
bacterial flora. Cases of a T. tenax infestation of workers in Eastern Europe and the 
Former Soviet Union are linked to periodontal disease (ACKERS, 2001). It is also 
reported that T. tenax can habitate the nasopharyngeal region and can cause 
pulmonal trichomonosis, when the patients had a pulmonal disease (STRATAKIS et al., 
1999). 
 
T. vaginalis is the only representative of the genus Trichomonas which is pathogenic 
for humans, and therefore the most relevant for human medical research. The genus 
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Tetratrichomonas is the most diversified one of the Trichomonas group, with 
representatives living in vertebrates, molluscs, and leeches,  and includes also one 
newly described species – T. undula sp. nov. –, which is the only known free-living 
species of the order Trichomonadida. The genus Trichomonoides contains only one 
member, T. trypanoides, which has been found in termites. Further species 
colonising Homo sapiens are Pentatrichomonas hominis (formerly referred as 
Trichomonas hominis) of the genus Pentatrichomonas, which is a non-pathogenic 
commensal of the ileum although it was reported to be associated with cases of 
diarrhea, and Dientamoeba fragilis of the genus Dientamoeba, family 
Dientamoebidae, order Tritrichomonadida, class Tritrichomonadea (thus not 
belonging to the Trichomonadea, although formerly it had been classified as member 
of the family Monocercomonadidae, order Trichomonadida after CAVALIER-SMITH, 
1998), which is assumed to evoke gastrointestinal symptoms, however, of low 
pathogenic potential (ACKERS, 2001; CEPICKA et al., 2010). 
 
All other members of the Trichomonadea are associated with animals and of different 
pathogenic potential.  
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1.2 Trichomonas vaginalis 
 
1.2.1   Morphology 
 
T. vaginalis is approximately 10 µm (5-15 µm) wide and 15 µm (8-25 µm) long. It 
appears as pear-shaped and oval, however, it also shows an amorphous-amoeboid 
morphology especially when attached to epithelial cells of the host (ARROYO et al., 
1993). It is also known that the parasite can appear as an over-dimensioned sphere, 
with or without flagella, and often with multiple nuclei. The reason for this 
phenomenon is not yet completely understood, but it may be a reaction to physical 
discomfort or a cellular developmental stage (ABONYI, 1995).  
 
The cell has four anterior flagella which are fixed on the apical pole. The undulant 
membrane runs along one side for about two-thirds of the length and is confined by 
the costa on the proximal side, which functions as a balancer, and by the fifth flagella 
on the distal side, which generates the wave-like motion of the membrane. The end 
of the flagellum is fixed in the pellicula. By flapping the free flagella, the parasite 
generates a hectic, staggering, and characteristic movement. The cell consists of 
plasma, nucleus, cytoskeleton, parabasal bodies, basal apparatus, axostyle, and 
hydrogenosomes. There are also granula for glycogen-storage, phagosomes and 
organelles, similar to lysosomes. The axostyle, a microtubular rod, divides the cell 
into two longitudinal halves and runs from the anterior to the posterior pole of the cell, 
where it breaks out as a sharp pinnacle. The purpose of this structure may be cell 
stabilization and for docking onto vaginal epithelial cells. Around the nucleus, the 
axostyle forms a collar-like pelta, which makes a cavity surrounding the nucleus and 
two parabasal bodies. The parabasal bodies consist of a modified Golgi apparatus 
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and two filamentous elements containing dictyosomes and fibrillae (Fig. 2). The 
cytoplasm contains glycogen granules, large vacuoles as well as free and 
membrane-bound ribosomes. Furthermore, T. vaginalis has no mitochondria, but 
hydrogenosomes which are analogous organella for an anaerobic metabolism. 
Mainly they are arranged alongside the costa and the axostyle (THOMASON & 
GELBART, 1989; ACKERS, 2001).   
 
 
 
Fig. 2: Schematic view of Trichomonas vaginalis (Original). 
 
 
 
 
 
 INTRODUCTION 
 
24 
1.2.2   Distribution 
 
T. vaginalis is distributed worldwide, occurs in every climate zone with no seasonal 
variability and was found in every racial group and socio-economical strata, with 
differences in incidence, though. In Central Europe, it is one of the three most 
frequent pathogenic protozoa, besides Toxoplasma gondii and Giardia lamblia. It 
cannot form cysts, hence, it is dependent on environmental factors like temperature 
and humidity for its survival. The only way for transmission is direct contact. Other 
ways of transmission as the common use of towels are only theoretically possible 
because the parasite can exist outside the human body only for a short time. 
Swimming pool water as a transmitter can be excluded (ACKERS, 2001).  
 
As a microaerophilic anaerobian with a pH optimum of 5.4–6.0, which correlates with 
the pH of the human vaginal milieu, the parasite is adapted for living in the 
genitourinary tract. There it lives on the epithelial layer of the anterior fornix vaginae, 
skene glands and urethra in women, and in urethra, prostate and occasionally under 
the foreskin in men. Results from in vitro studies have indicated a pH optimum of 
6.0–6.3 and a decrease of motility below 4.5 (DIAMOND, 1986). At 0°C, the organism 
can survive for up to 5 days, however, at 60°C and above, it is killed within 4 minutes 
(THOMASON & GELBART, 1989). Crucially, T. vaginalis is very sensitive to dehydration 
and can survive in bath waters with its different osmotic value from 30 minutes to 3 
hours and in chlorinated swimming pool waters (44 mg/l) only for a few seconds to 
minutes. In supply water, the survival span can reach up to 24 hours. As mentioned 
before, Homo sapiens is the only natural host of T. vaginalis, however, 
experimentally it can infect and breed it in the urogenital tracts as well as in the 
peritoneum of mice (ACKERS, 2001; WALOCHNIK & ASPÖCK, 2002). 
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1.2.3  Life cycle 
 
T. vaginalis is an extracellular parasite and does only exist in the trophozoite stage. 
Vectors or cysts for transmission are not needed as it is directly transmitted from 
human to human during sexual intercourse. The trophozoite feeds by pinocytosis, a 
specification of phagocytosis, and ingests bacteria, yeasts, and erythrocytes, 
whereas liquids and solved nutrients are taken off by pseudopodia-like extensions 
(THOMASON & GELBART, 1989). 
 
T. vaginalis reproduces by longitudinal binary fission every four to six hours, but in 
contrast to other eukaryotes the nucleus membrane does not disappear during this 
event. The nucleus divides by kryptopleuromitosis in which the spindle is located 
outside the nucleus. After disaggregation of the axostyle, the flagella double and the 
mitosis starts by forming two attractophores on both sides of the nucleus that become 
the poles of mitosis. From there, microtubules reach into the nucleus and attach on 
the centromeres. The extranuclear spindle between the attractophores, called 
paradesmose, elongates and the cell divides when nuclei and flagella migrate to 
separate poles. Subsequently, daughter cells produce the missing organella. Round 
forms – as mentioned in 1.2.1 – are assumed to divide by amitotic budding. Some 
species of the Trichomonadida are also able to form pseudocysts that are not 
protective but allow a faeco-oral transmission. Hence, it is assumed that T. vaginalis 
has lost its ability to form cysts as a result of its obligatory parasitic lifestyle and the 
direct way of transmission (PETRIN et al., 1998). 
 
Interestingly, T. vaginalis also seems to have a meiotic recombination machinery as 
27 of 29 resembling meiotic genes were found as ortholog genes. Due to the 
presence of 21 of these genes also in Giardia intestinalis, the meiosis machinery 
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seems to be present in a common ancestor of both organisms and, hence, occurred 
early in the evolution. This theory is supported by the high genetic variation between 
T. vaginalis strains (MALIK et al., 2008). 
 
 
1.2.4  Metabolism  
 
The energy metabolism of T. vaginalis is, along with those of Giardia and 
Enteromonas, more similar to anaerobic bacteria than to eukaryotes. Trichomonads 
lack mitochondria and peroxisomes, thus they can oxidize glucose only partially and 
cannot catabolise H2O2. Moreover, their parasitic habitus also seems to result from 
their disability to synthesize nucleic acids, so that they have to incorporate purines 
and pyrimidines from their host cells. Adenine and guanine salvage is mediated by 
nucleoside phosphorylases and kinases, whereas thymine, cytidine and uracil are 
metabolized by phosphoriboysltransferases and nucleoside kinases. Nucleosides are 
transferred through the cell membrane by active carrier transport and are converted 
into nucleotides by specific kinases (PETRIN et al., 1998).  
 
De novo lipid biosynthesis is confined to the phospholipid phospatidylethanolamine, a 
component of the cell membrane. Other lipids, including cholesterol, are most likely 
aquired from exogenous factors because of the absence of their enzyme-coding 
genes and degradation of the metabolic pathways (CARLTON et al., 2007).   
 
Amino acids are consumed in higher amounts when the main energy source, 
carbohydrates, is not available or limited (PETRIN et al., 1998). Carbohydrate 
metabolism takes place in the cytoplasm, where glucose is converted to 
phosphoenolpyruvate and pyruvate via glycolysis (Emden-Meyerhoff-Parnas 
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pathway), and subsequently in the hydrogenosomes, where pyruvate is oxidatively 
decarboxylated to acetyl-coA by the enzyme PFOR. In the respiratory chain, acetyl-
coA is conversed to acetate, coenzyme A, and ATP. Under physiological stress, T. 
vaginalis decreases the activity of hydrogenosomal enzymes and changes to 
cytosolic conversion of pyruvate to lactate by enhanced activity of the enzyme LDH. 
The catabolic end products of T. vaginalis are acetate, lactate, malate, glycerol, CO2, 
and H2 (KIM et al., 2006; LEITSCH et al., 2010; PETRIN et al., 1998).  
 
Hydrogenosomes are organelles with a size of 0.5–1 µm and represent an analogue 
to mitochondria in anaerobic organisms. Contrary to them, they lack cristae, 
cytochromes, and also own DNA, (except in the ciliate Nyctotherus ovalis) – which 
corroborates the theory of a common ancestor of hydrogenosomes and mitochondria 
(the hypotheses on the origin of hydrogenosomes range from modified or 
degenerated mitochondria to the endosymbiosis of anaerobic bacteria in eukaryotic 
cells). The main function of the hydrogenosomes is the generation of energy by 
substrate-levelphosphorylation of acetyl-coA to ATP (HACKSTEIN et al., 2001; PETRIN 
et al., 1998). 
 
The ATP-generating pump works identically as those in mitochondria, however, it 
loses its function in the presence of oxygen as it is catalyzed by the strictly anaerobic 
enzyme hydrogenase. Due to the production of hydrogen and the consecutive 
conversion to methane by methanogenic bacteria, anaerobic protozoa with 
hydrogenosomes also contribute to the greenhouse effect significantly. PFOR is also 
supposed to play a role in the resistance mechanism against metronidazole (MÜLLER, 
1986; MÜLLER, 1990; KULDA, 1999). 
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1.2.5   Genetics 
 
The karyotype of the Trichomonadida depends on the species and varies from three 
to twelve chromosomes. T. vaginalis contains six chromosomes, comprising of three 
maxichromosomes, two intermediate chromosomes, and one minichromosome. The 
same number of chromosomes was found in 15 isolates of T. vaginalis from different 
geographic regions, which supports the theory of a highly conserved karyotype within 
the genus Trichomonas (LEKHER & ALDERTE, 1999).  
 
In 2007, the “T. vaginalis Genome Project” was completed by CARLTON et al. (2007), 
and the draft genome sequence was published. The whole size of the genome was 
found to be 160 megabases (Mb) in size, which is about tenfolds larger than originally 
estimated by LEKHER & ALDERTE (1999). About 60.000 protein-coding genes were 
identified, which is more than in Homo sapiens with “only” 30–40.000 coding genes. 
Moreover, more than two thirds of these genes contain repeats and transposable 
elements. It is assumed that this enlargement of the genome occurred by lateral gene 
transfer from bacteria, viruses, and phagocytosis from host proteins as well as by the 
parasite’s relocation from the digestive into the urogenital tract. An enlargement of 
the genome might correlate with an enlargement of the cell (T. vaginalis cells are 
distinctly larger than those of other Trichomonadida) – probably a benefit at 
colonizing new habitats. Numerous of the identified genes are responsible for specific 
metabolic pathways and pathomechanism. About 800 genes stand by for the process 
of attachment on host cells, about 400 are reponsible for the degradome (protein- 
degrading peptidases) (CARLTON et al., 2007).  
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A recent study has shown that in case of the transmembrane adenylyl cyclase genes 
(TMAC genes), a high percentage are pseudogenes (46%) and the high number of 
gene copies result from a recent duplication of a small ancestral gene family. 
 
Especially mavericks – giant transposable elements – are abundant and constitute 
30% of the total genome and 50% of the putative protein-coding genes (PRITHAM et 
al., 2006; CUI et al., 2010). Introns and non-coding elements can be no explanation 
for the large-scale genome amplification as they are rare and short. In T. vaginalis, 
only 65 introns have been identified. Additionally, the size of the genome appears not 
to be correlated to pathogenicity although the largest genomes were found in the 
pathogenic species T. vaginalis and T. foetus (177 Mb). However, a similar genome 
size was found in the non-pathogenic species T. augusta, a harmless commensal in 
reptile intestines, (165 Mb) and T. tenax (133 Mb), whereas the smallest genome was 
found in the bird-pathogen T. gallinarum (86 Mb) (ZUBÁČOVÁ et al., 2008). 
 
Arguably, a high polymorphism between microsatellite markers of a population of 
common laboratory strains indicates that T. vaginalis is a genetically diverse 
organism, however, sequencing of 5.8S rDNA and the flanking ITS regions of T. 
vaginalis isolates from sex workers on the Philippines showed low genetic 
polymorphism between the strains (RIVERA et al., 2009; CONRAD et al., 2010). 
 
The identfication of genes for the biosynthesis of common cytosolic FeS proteins 
gives a distinct support of the hypothesis that hydrogenosomes may have their origin 
in mitochondria. Furthermore, hydrogenosomes may also be able to metabolize 
amino acids. The existence of an RNA interference pathway might be a possible 
target for developing drugs manipulating the parasite’s gene expression (CARLTON et 
al., 2007). 
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1.3    Trichomonosis 
 
1.3.1   Epidemiology 
 
T. vaginalis is the causative agent of trichomonosis and therefore of high medical and 
socio-economical relevance. Trichomonosis is the most frequent non-viral sexually 
transmitted disease, with 174 million cases globally and an incidence of 2–3 million 
new infections annually (WHO, 2001; NIAID, 2003). Prevalence varies from region to 
region and ranges from 3% in the USA (ALLSWORTH et al., 2009), over 10–20% in 
Europe and the Republic of Korea (ASPÖCK, 1994; RYU & MIN, 2006) up to 31% in 
Mozambique (MENÉNDEZ et al., 2010) and 40% in Papua New Guinea (VALLELY et al., 
2010). From Mongolia, a prevalence of 67% was reported (SCHWEBKE et al., 1998). In 
Vienna, Austria, the prevalence of T. vaginalis in prostitutes was found to be 
approximately 5% (STARY et al., 1991).  
 
Studies from the USA have shown that trichomonosis is 12 times more prevalent 
among black women, besides it correlates also positively with young age, high 
frequency of changing sexual partners (especially with older partners), high poverty 
level, other genital infections (especially Neisseria gonorrhoeae, Chlamydia, herpes, 
warts), and low educational and hygienic level (ALLSWORTH et al., 2009; KRASHIN et 
al, 2010). A much higher prevalence – from 8.5% to 47% – was also found in female 
US jail and prison inmates (SUTCLIFFE et al., 2010). Moreover, in Greece T. vaginalis 
was more frequently detected in immigrants (8%) than in native women (3%) 
(PIPERAKI et al., 2010). 
 
The maximum prevalence is between 20 and 45 years, which is of higher age than 
for the most sexually transmitted diseases. However, this correlates with the age of 
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maximal sexual activity. High-risk groups are prostitutes and promiscuous individuals. 
Besides, an altered vaginal pH milieu, caused by hormonal changes like birth control 
pill or pregancy, leads to a stronger incidence of infections with T. vaginalis. With the 
beginning of the menopause, the disease often heals spontaneously (PETRIN et al., 
1998). Infected mothers can transmit trichomonads to their child during birth 
(perinatal mode of infection) with a risk of approximately 5%. In this case, the child 
can aquire an infection of trichomonads in the urogenital tract, however, the infection 
heals spontaneously a few weeks after birth and requires normally no treatment 
(WALOCHNIK & ASPÖCK, 2004). Trichomonads can even be detected in infants – in this 
case, it is mainly an evidence for sexual child abuse (LEWIN, 2007).  
 
 
1.3.2  Clinical manifestations 
 
The habitat of T. vaginalis is the human urogenital tract where it colonizes the 
mucosal epithel cells. Both women and men can be infected and act as a vector for 
transmission. In women, the disease occurs mainly between adolescence and 
menopause. Primary affected organs are vagina, cervix and – additionally – urethra 
in 75–90% of the cases, whereas bladder and uterus are not affected normally. In 
50% of infected and symptomatic women, the incubation time is between 4 and 28 
days (THOMASON & GELBART, 1989; PETRIN et al., 1998). 10–50% of infected women 
show no symptoms and also have a normal vaginal flora and pH. However, 50% of 
these women will develop symptoms within the next six months (PERAZZI et al., 
2010). 
In contrast to women, infections with T. vaginalis are asymptomatic in men in 90% of 
the cases. The parasite could be detected in 72% of male partners of infected 
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women, of whom 78% were asymptomatic. These cases may lead to misdiagnosis 
which supports further distribution (SEÑA et al., 2007). The incubation time in 
symptomatic men is approximately 10 days, in which the trichomonads colonize the 
foreskin, urethra, and prostate gland. In about 10% of the cases, urethritis and 
prostatitis can occur. In women, the symptoms are more severe and include mostly 
considerable irritations with a fulminant vaginitis. The first symptoms are strong 
urgency, pain at urinating, and itching of the vagina. Typical symptoms are a sore 
and reddend vulva, an edematous and reddend vagina, “fluor vaginalis” (a foamy, 
malodorous, viridescent discharge), and a “strawberry-cervix” (punctual, hemorrhagic 
lesions in the vaginal cervix). Furthermore, the number of leukocytes in and the pH-
value of the vagina can be increased dramatically, thus the vaginal flora is altered 
and susceptible for further infections. Dyspareunia and postcoital hemorrhage can 
also occur. When therapy fails, the acute stage fades into a chronic stage, in which 
the symptoms continue but in a far milder way, being ignored often. This is also an 
important factor for the transmission of the disease (PETRIN et al., 1998).  
 
In many cases, the symptoms are unspecific and can be confounded with those of 
other veneral diseases. The “strawberry cervix” is observed in 2% of cases and “fluor 
vaginalis” in 12% of cases only (FOUTS & KRAUS, 1980). 
 
Even though trichomonosis is not a lethal disease, an infection can impair health and 
life quality severly. Besides the above mentioned symptoms, it is also believed that 
an infection with T. vaginalis can cause complications during pregnancy including 
damage of the placenta, higher risk of premature birth and a low birth weight (COTCH 
et al., 1997). Furthermore, there seems to be a coherence of trichomonosis and 
cancer, especially when the infection has passed into the chronic stage. Steadily 
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inflamed urogenital organs like ovaries and prostate gland have a higher risk to 
develop neoplasia and cancer (SUTCLIFFE et al., 2009). In rare cases, a fulminant 
infection may also lead to temporary sterility (EL-SHAZLY et al., 2001). 
 
In 2008, an acquisiation of trichomonads in neonatals during their passage through 
the birth canal and conseqently evoked infections of the childrens’ respiratory tract 
could be detected (CARTER & WHITHAUS, 2008). 
 
Finally, it is reported that trichomonosis may increase the risk for co-infections, not 
only for fungi (Candida) and bacteria (Mycoplasma), but also for HIV as an infection 
with T. vaginalis leads to a weaker integrity of the epithelial cells, to a decreased 
innate immunity and an accumulation of HIV-affine cells like lymphocytes and 
macrophages (LAGA et al., 1993; SORVILLO et al., 2001; THURMAN & DONCEL, 2011). 
 
 
1.3.3   Pathomechanism 
 
T. vaginalis is an extracellular parasite and primary affine to erythrocytes and vaginal 
epithelial cells but also to immune cells and vaginal bacteria. Additionally, T. vaginalis 
internalizes also viruses like HIV and human papillomavirus and can act as a Trojan 
horse for bacteria such as Mycoplasma that survives and multiplies inside the 
trichomonad cell. Similarly, after being tranferred from one person to another, T. 
vaginalis can support the spread of HIV by this way (TAYLOR-ROBINSON, 1998; HIRT et 
al., 2007). 
 
The mechanism of pathogenesis is complex – as well not fully understood yet – and 
includes cell-cell-adhesion, haemolysis, excretion of lytic factors, endocytosis of host 
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cell content, and degradation of immunoglobulins and complement proteins (HIRT et 
al., 2007).  
 
Adhesion to epithelial cells is an essential step in pathogenesis. T. vaginalis attaches 
with the side opponent to the undulant membrane, changing from its ovoid shape to 
an amoeboid form. This step depends on temperature, pH value, and time span of 
contact. A key protein of this action is alpha-actinin, an actin-binding protein that 
participates in the morphological transformation by the redistribution of actin. Hence, 
the parasite’s shape becomes amoeboid-amorphous and capable for adhesion onto 
host cells. In vitro studies have shown that motile parasites form large aggregates 
and recruit other parasites. After a few hours, retraction, rounding, and detachment of 
the epithelial cells were observed (ALDERETE & GARZA, 1985; FIORI et al., 1999). 
Adhesion seems to be dependent on adhesion proteins (AP65, AP51, AP33, AP120, 
AP23) and certain components of the glycocalyx of the cell membrane, especially its 
main component, lipophosphoglycan (LPG). In vitro studies have shown that LPG 
defective mutants have less adherence and cytotoxicity for human ectocervical cells 
(BASTIDA-CORCUERA et al., 2005; ZHANG et al., 2010).  
 
Regarding the adhesion proteins, it is reported that lectins, considered as important 
virulence factors also in other pathogens (f.e. Entamoeba histolytica), could be 
involved in the adhesion process via binding to sugar moieties from glycoconjugates 
of host cells. Furthermore, hydrogenosomal enzymes are claimed to have dual 
cellular localizations as surface proteins, where they function as adhesins (so called 
“moonlighting proteins”). Although these data are controversial, it could be proved 
that the adhesion protein AP120 is identical to the hydrogenosomal enzyme PFOR. 
In this context, an outstanding feature is the absence of glycoyslphosphatidylinositol-
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anchored surface proteins which are characteristic for eukaryotes (MORENO-BRITO et 
al., 2005; HIRT et al., 2007). 
 
Haemolysis is dependent on temperature, pH value, Ca2+, effector concentration, and 
includes several steps. After adhesion, cysteine proteinases – transmembrane pore-
forming proteins – induce lysis of host cells by pore formation and can also 
manipulate the host’s immune systeme by degrading antibodies. For example, CP39, 
one of the best characterized cystein proteinases, is able to degrade collagens I, III, 
IV, and V, human fibronectin, hemoglobin, and immunoglobulins A and G 
(HERNÁNDEZ-GUTIÉRREZ et al., 2004).  
 
During this step of haemolysis, the parasite detaches from the cell via a specific cell-
detaching factor (CDF) and the contents of the lysed cell are phagocytosed. Red 
blood cells are a means for acquiring lipids and iron, essential nutrients for the 
parasite. It was also found that spectrin, the main protein of the cytoskeleton of the 
membrane of red blood cells, is totally absent after exposure to T. vaginalis. This may 
be a strategy of the parasite to increase the sensivity of host cells to pore-forming 
proteins (FIORI et al., 1999). A decrease of cysteine proteinase expression also 
correlates with a low virulence phenotype (DE JESUS et al., 2008).  
 
Recently, it was found that not only cysteine proteinases may be involved in 
pathogenicity; the first putative serine proteinase (SUB1; subtilisin-like serine 
protease) was identified and characterized (HERNÁNDEZ-ROMANO et al., 2010). The 
emergence of inflammation may be contributed to the recruitment and accumulation  
of neutrophils by the release of chemokines by T. vaginalis like IL-8 and GRO-α (RYU 
& MIN, 2006). 
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An additional important factor in regulating virulence is iron, as trichomonads exhibit 
less cystein proteinase activity and therefore low cytotoxicity levels at highest iron 
concentrations and vice versa (ALVAREZ-SÁNCHEZ et al., 2007).  
 
T. vaginalis has allocated a great many of gene clans and families and proteins for its 
pathomechanism. There are about 800 genes for the process of cell-cell-adhesion 
and about 23 different proteinase activities (LEÓN-SICAIROS et al., 2004; CARLTON et 
al., 2007). Curiously, proteins like CDF can even act independently from direct cell 
contact. It could be shown that epithelial cells in a trichomonad-free filtrate containing 
CDF react by rounding and detaching from the culture flask (GARBER et al., 1989). 
 
An important role in pathogenesis accords to the interactions of T. vaginalis with the 
vaginal flora. The population of Lactobacillus acidophilus, an important symbiont of 
the vaginal milieu, can be reduced or disappear following on a massive reproduction 
of trichomonads. Consequently, the pH value – normally at 4.5 – can be deranged as 
trichomonads prefer a pH >5 which is disadvantageous for vaginal bacteria. Further 
co-infections can also appear, especially with Candida and Mycoplasma hominis 
(PETRIN et al., 1998; vAN BELKUM et al., 2001). 
 
 
1.3.4    Diagnostics 
 
Due to the mentioned unspecific symptoms of trichomonosis, laboratory diagnosis is 
of major importance and focused on the direct detection of parasites in vaginal 
smears. If diagnosis is based only upon the classic clinical symptoms (“strawberry 
cervix”, frothy discharge), 88% of infections cannot be diagnosed, and 29% of 
uninfected women would be false positive in being infected (FOUTS & KRAUS, 1980). 
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In men, trichomonads are more difficult to detect than in women, as they occur in 
lower numbers and may be reduced by micturition too. In women, the pH value –
measured on Nitrazine paper – is elevated and can be as high as 6.0. Sample 
collection is performed with cotton-tip swabs from the anterior and lateral vaginal 
fornices, prostatic secretions, and semen. Mucosal cells from the urethra can be 
collected on a wire loop (THOMASON & GELBART, 1989; RAJEBALI, 2008).  
 
Wet-mount examination by phase-contrast, dark-field or bright-field illumination is a 
simple and fast diagnostic method. The secretions are inoculated onto a drop of 
physiological saline on a slide and examined. However, this method is of low 
specificity and has a sensitivity rate from as low as 38% to as high as 92% as the 
secretions contain not only trichomonads but bacteria and leukocytes too. 
Trichomonads often appear as rounded forms that are similar to the shape of white 
blood cells. They can be clearly identified by their motility. However, they have a 
limited life span outside of the human body, which depends on the temperature and 
sample material. Using wet-mount examination it is only possible to detect living 
trichomonads in at most three-quarters of infected women and only in 1–20% of 
infected men (THOMASON & GELBART, 1989; PETRIN et al., 1998; ACKERS, 2001). 
 
Culture in Kupferberg Medium or Modified Diamond Medium provides a higher 
reliability. However, although this technique is simple and requires only 300–500 
trichomonads/ml of inoculum to obtain a growing culture, it has its limitation in its 
incubation period of 2 to 7 days. During this time, infected patients can further 
transmit the parasites. Methods like the InPouch system and the plastic envelope 
method combine the promptness of wet-mount examination with the high sensitivity 
(97%) of culture, improving the specificity up to 100% (PETRIN et al., 1998). 
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Staining techniques such as Papanicolaou, acridine orange, Leishman, periodic acid- 
Schiff and also Giemsa and Eosin increase the sensitivity of direct microscopy. It 
allows distinguishing similar shaped trichomonads from white blood cells, although 
sometimes the typical morphological features are altered or lost during fixation and 
staining. Used solely, staining has a fairly low specificity and sensitivity due to a high 
number of false positive and false negative findings (THOMASON & GELBART, 1989; 
PETRIN et al., 1998; RAJEBALI, 2008). 
 
Staining methods using monoclonal antibodies maintain a sensitivity (80.6%) and 
specificity (98.6%) similar to that of culture. Trichomonas Direct Enzyme 
Immunoassay and Fluorescent Direct Immunoassay (California Integrated 
Diagnostics, Benicia, CA) use peroxidise- and fluorescent-labeled cocktails of 
monoclonalantibodies, making structures like membrane, cytoplasm, nuclei, and 
flagella visible. The examination can be performed with an ordinary light microscope 
within 1 hour. As even nonmotile trichomonads can be detected and it approves both 
diagnosis and treatment at a single consultation, this method is suitable for most 
clinics and physicians (THOMASON & GELBART, 1989). New tests as the OSOM 
Trichomonas Rapid Test (Genzyme Diagnostics) and the Affirm VP III (Becton 
Dickenson) are promising with a sensitiviy >83% and a specificity >97% (WENDEL & 
WORKOWSKI, 2007). 
 
Serological methods such as agglutination, complement fixation, and enzyme-linked 
immunosorbent assay may be applied to detect antitrichomonal antibodies, however, 
they are not suitable as first time diagnostics because it is not possible to distinguish 
between current and past infections. Trichomonal antibodies may persist for a long 
time after healing of the infection. In general, the sensitivity is low in solely used 
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serological methods: if the level of antibodies is too low or the serum humoral 
response can not be elicited, it will not be possible to perform a successful diagnosis 
(PETRIN et al., 1998). 
 
With the establishment of molecular biological methods in most laboratories, PCR is 
the primary method of choice in diagnosis nowadays. By this technique it is possible 
to detect even low numbers of pathogens by repeating amplification of a specific part 
of the genome (SAIKI et al., 1988). Sensitivity and specificity of an established PCR 
for T. vaginalis were calculated as 97.8% and 97.4%, respectively, for genital 
samples and 80% and 99.6 %, respectively, for urine samples. Hence, the reliability 
is similar to that of culture and, in contrary, enormously time-saving (JORDAN et al., 
2001; VATANSHENASSAN et al., 2010).  
 
Due to the disadvantage of high costs, a combination of PCR and microscopic 
examination seems to be most reasonable (LAB TESTS ONLINE, 2007). Today, co-
infections by T. vaginalis and other pathogens as Mycoplasma hominis and 
Ureaplasma urealyticum can be detected rapidly with a newly established multiplex 
PCR (DIAZ et al., 2010). 
 
 
1.3.5   Therapy 
 
The medical treatment of trichomonosis is performed mainly by chemotherapy, and in 
this case, metronidazole has been the drug of choice since it was discovered by 
scientists of the Pasteur Institute in 1959 (COSAR & JULOU 1959). It is applied orally 
mostly, but can also be applied as vaginal suppository. After uptake, the drug is 
absorbed by the mucosa, resorbed in the gut, catabolized in the liver and excreted by 
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the kidneys with a bioavailability of 90% and higher. The dosage regimen is referred 
as 750 mg three times a day for 7 days or as a single dose of 2 g, with a success rate 
of 82% to 88% and even 95% when all sexual partners are treated simultaneously 
(NIX et al., 1995; PETRIN et al., 1998).  
 
Metronidazole belongs to the chemical class of 5-nitroimidazoles and has a high 
tolerability in general, nevertheless, there are some side effects as headache, 
metallic taste, anorexia, nausea, parasthesia, allergic reactions, neuropathy, and 
malfunctions of the digestion can occur. Furthermore, in some cases neutropenia, 
hepatitis, and jaundice have been reported. Metronidazole must not applied when 
diseases of the central nervous system, blood, and liver are present, and also during 
the pregnancy/lactation period, especially in the first trimester, due to its putative 
teratogenic potential. Studies in mice have attributed a cancerogenic effect to 
metronidazole as it provokes lung tumours after long-term application of high doses. 
Alternative drugs for treatment, although of lower effectivity, are clotrimazole, a 
combination of tinidazole and paramomycin, carnidazole, ornidazole, secnidazole, 
flunidazole, and nimorazole. Amphotericin B, a broadband antibiotic generally used 
against infections with Naegleria, Leishmania and Trypanosoma, can also be applied 
against trichomonosis although it has severe nephrotoxic potential (PETRIN et al., 
1998; ACKERS, 2001; REDIGUIERI et al., 2011). 
 
Resistance to metronidazole is a serious problem and a reason for treatment failure. 
It is reported from laboratory strains since the 1960s and from patient isolates since 
the late 1970s (RASOLOSON et al., 2002). Collateral to the broad use of metronidazole 
against trichomonosis, resistance is increasing due to adaptation of the parasite to 
the drug’s mode of action. Treatment failure as the exposure of trichomonads to 
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sublethal drug concentrations may lead to resistance and, furthermore, cross 
resistances to other nitroimidazoles – to which most of the antitrichomonal drugs 
belong – occur more frequently. Resistance may be overcome with higher and 
increasing doses. An alternative treatment of metronidazole-resistant strains is 
possible with tinidazole, however, it is successful only in a limited number of cases 
(KULDA, 1999; NYIRJESI, 1999; WENDEL & WORKOWSKI, 2007). Hence, there is a 
requisition for new antitrichomonal agents with a similar effectivity of metronidazole 
but a different mode of action.  
 
Finally, it is important that not only the infected patient gets treated but also all sexual 
partners to avoid reinfections. Sexual intercourse should not be practised during the 
duration of treatment (PETRIN et al.,1998). 
 
 
1.3.6    Immunity and prophylaxis 
 
A vaccine is not available against T. vaginalis to this date. A reason might be the 
complexity of the interactions between host and parasite, which is generally the main 
problem in the establishment of vaccines against parasites (LUCIUS & LOOS-FRANK, 
2008).  There is no protective immunity of H. sapiens against T. vaginalis, even after 
repeated infections. Cell-mediated immune response was found to be invoked as well 
as anti-trichomonal antibodies IgA, IgG, IgG subclass, and IgM were found to be 
present during and a few months after an infection but an acquired, protective 
immunity could not be confirmed to this date. An explanation may be the antigenic 
heterogeneity of the parasite. However, innate mucosal immunity exists. Interestingly, 
in mice – although H. sapiens is the only natural host for T. vaginalis, it is also 
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possible to breed it in the peritoneum and urogenital tract of mice (see 1.2.2) – 
immunity could be achieved after subcutaneous infection of living trichomonads. 
Amazingly, a protection could not be achieved after vaginal infection. Thus, also the 
localization of the pathogen in the vagina may play a role in systemic antigen 
presentation and acquiring immunity (ABRAHAM et al., 1996; KAUR et al., 2008; 
THURMAN & DONCEL, 2011).  
 
As mentioned before, an infection with T. vaginalis must not lead to symptoms 
obligatorily, and even if it does, spontaneous healing can occur, particularly in men. It 
is assumed that production of cervical IL-8 and vaginal ∝-defensins, mediated by T. 
vaginalis itself, and the consecutive infiltration with neutrophiles in the local area play 
a role in infection healing and asymptomatic infections, as neutrophiles have 
potential in killing pathogens and are important mediators in inflammatory regulation 
(BRENIER-PINCHART et al., 2001; SIMHAN et al., 2007).  
 
The parasite may also be able to be resistant against the complement system which 
is present in the menstruation blood but not in the mucosa. It was found that a high 
level of iron supports a resistance, whereas low iron levels lead to more killing of 
trichomonads by the complement. This knowledge and the fact that many virulence 
factors of T. vaginalis are iron-mediated may be an explanation why the symptoms 
are more serious during the menses (ALDERETE et al., 1995). 
 
As in other veneral diseases, the best prophylaxis is the use of condoms and the 
avoidance of promiscuitivity. Educational campaigns, controllings of risk groups, and 
a treatment of all sexual partners of the patient amend the prophylactic methods. A 
reduction of the time span of infection and an efficient treatment are important to 
control the spreading of trichomonosis (WALOCHNIK & ASPÖCK, 2002). 
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1.4   Scientific background 
 
1.4.1  Pentamycin – a polyene antibiotic 
 
Pentamycin was discovered and described in 1958. It has been investigated as a 
drug against fungal infections, like candidiasis, a common co-infection of 
trichomonosis (UMEZAWA et al., 1958; CHEN et al., 1978; BALMER, 2009). 
 
Chemically it belongs to the polyenes, a subdivision of the macrolide class. 
Substances in this class are characterized by a macrocyclic ring of carbon atoms 
closed by lactonization. The polyene group has, in addition, a series of conjugated 
carbon-carbon double bonds. The number of these bonds allows to classify polyenes 
into dienes (two bonds), trienes (three bonds), tetraenes (four bonds), pentaenes 
(five bonds), hexaenes (six bonds) and heptaenes (seven bonds) (HAMILTON-MILLER, 
1973) .  
 
A feature allowing classification of polyenes is the highly characteristic ultraviolet 
absorption spectrum, leading to specifically emitted colors: Trienes are colorless, 
tetraenes are pale yellow, pentaenes are yellow, and heptaenes appear orange. 
Many polyenes are amphoteric, possessing one basic and one acidic group, and also 
many act as antibiotics, mainly antifungals, and are produced by several 
Streptomyces species. The most effective antifungals belong to the heptaenes, like 
amphotericin B and candicidin, but also trienes, tetraenes, pentaenes and hexaenes 
include such strong substances. As its name indicates, pentamycin belongs to the 
pentaenes (HAMILTON-MILLER, 1973). 
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All polyenes interact with sterols in the cell membrane that are ergosterol in fungi and 
cholesterol in protozoa and higher eukaryotes, where they alter the permeability of 
the membrane, lead to K+ leakage, inhibition of glycolysis and finally to cell lysis. 
Differences in the mode of action have been noted in the ion selectivity of membrane 
pores produced, the relative preference for cholesterol- or ergosterol-containing 
membranes and in progressive or “all-or-none” modes (KOTLER-BRAJTBURG et al., 
1979). In the 1960s, it was believed that polyenes are toxic for fungi and some other 
eukaryotes but not for bacteria due to their different membrane composition and lack 
of sterols. However, it was found out later that some polyenes like amphotericin B 
and nystatin are toxic for bacteria like Acholeplasma laidlawii too (DE KRUIJFF et al., 
1974). Regarding the effectivity of the polyenes, it seems that their toxicity is only 
outweighed by the lack of resistance occurring to them (HAMILTON-MILLER, 1973). 
 
However, only a few polyenes have found their way into clinical treatment, the most 
known among them is amphotericin B. It is applied against all human pathogenic 
fungi and some protozoa like Leishmania, Trypanosoma, Naegleria, and also T. 
vaginalis. Especially against the severe diseases visceral leishmaniosis and primary 
amoebic meningoencephalitis it is used as drug of last resort. Its disadavantages are 
its side effects, which can lead to severe and permanent kidney damage in the worst 
case. According to its clinical use, it is one of the most toxic polyenes for mammals 
too:  Experiments have shown a LD50 in mice of 280 mg/kg after intraperitoneal 
application and >8,000 mg/kg after oral application. In comparison, pentamycin has 
shown a LD50 of 33.3 mg/kg after intraperitoneal application and 1,624 mg/kg after 
oral application (CARTER, 1969; OLLER, 1969; HAMILTON-MILLER, 1973; HAIDO & 
BARRETO-BERGTER, 1989; PAILA et al., 2010). 
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Pentamycin (C35H60O13), produced by the actinomycete Streptomyces pentaticus, 
has been in laboratory use against fungal infections since then, in particular against 
candidiasis, since the 1960s but has also been described as an enhancer of the 
potent antitumor agent bleomycin (NAKASHIMA et al., 1974; ZYGMUNT, 1966). As 
recently as in 2009, it has been described as a successful drug in clinical use against 
infections with Candida albicans: Submitted as a vaginal tablet, it does not penetrate 
into the circulation due to its high molecular weight (670.85 g/mol) and bi-polar 
structure, which contributes to its tolerability. Because candidiasis is a common co-
infection of trichomonosis, it was noticed that the efficacy is also significant in case of 
trichomonosis (BALMER, 2009). 
 
The clinical importance of a new and effective drug in treating trichomonosis is 
getting distinctively due to the increasing resistance of T. vaginalis against 
metronidazole on which several theories exist meanwhile about the mechanism of 
resistance (MÜLLER, 1986; HRDY et al., 2005; LEITSCH et al., 2009). 
 
 
1.4.2  The field of proteomic research  
 
 The term “proteome” is a cross between “protein” and “genome” and means the 
entirety of proteins in a cell or an organism, as transcriptome means the entirety of 
mRNA and genome the entirety of genes. Proteomics is the investigation of the 
proteome and can give an insight into the actual genomic activity of the cell. Because 
the genome is only the blueprint of its transcripts, the status of a cell or organism is 
much better represented by its expressed proteins. 
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In contrary to the genome (aside from epigenetic regulation mechanisms), the 
proteome shows a highly dynamic activity as the span of expressed proteins differ 
from cell to cell and from time to time. Some proteins persist only for a few seconds 
whereas others can outlast for years. Also, it is not possible to conclude the number 
and functions of proteins from the genes because post-translational modifications of 
mRNAs (poly adenylation, capping, splicing, exon shuffling,Z) and also of proteins 
(glycosylation, acetylation, phosphorylation, methylation,Z) can lead to various 
functional proteins that are expressed by one single gene – or vice versa, as several 
genes may contribute to the transcript of one single protein. Finally, the activity of 
proteins also depends on their primary, secondary, tertiary, and quartary structure as 
well as new functions can emerge when proteins assemble to-gether to a complex 
(KNIPPERS, 2001) . 
 
To simplify this complex research field, the aims of proteomics can be abstracted into 
two chapters (KNIPPERS, 2001; MURKEN et al., 2006): 
 
• first, the identification and characterization of proteins, performed by 2D SDS-
PAGE (two-dimensional sodium dodecylsulfate polyacrylamide gel 
electrophoresis) and subsequent mass spectroscopy 
 
• secondly, the investigation of the function of proteins, including the localization of 
specific proteins in the cell, performed by enzymatic tests and genetic methods 
like knockout-mutants, reverse genetics, mutant phenotypes, and other methods 
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Alongside with the successful identification of the draft genome sequence of T. 
vaginalis, the research of its proteome has improved too in the last years. A study of 
2009 by HUANG et al. has published a proteome reference map of the parasite by 
using 2D SDS-PAGE and MALDI-TOF mass spectroscopy. It was observed that the 
majority of the expressed proteins is settled in the acidic pH milieu, maybe due to the 
adaptation to the vaginal milieu. The identified proteins were classified into energy 
production and carbohydrate metabolism, cytoskeleton, defense and stress-related 
responses, nucleotide metabolism, pathogenesis and other. The most abundant 
group was responsible for energy metabolism (24.7% of total) that is located in both 
cytosol and hydrogenosomes. However, cytoskeletal proteins and cysteine 
proteinases, that participate both in the pathogenesis process as well as antioxidant 
proteins like thioredoxin reductase, accounted a considerable amount for the T. 
vaginalis proteome too (HUANG et al., 2009). 
 
Furthermore, a study of 2007 has shown that trichomonads, cultivated in an iron-
depleted medium, display a different protein profile than those grown in iron-rich 
medium. Iron is an important nutrient, and a lack causes alterations in the 
morphology and the metabolism, forcing the organism to change to alternative 
metabolic pathways. Enzymes involved in energy metabolism, proteolysis and 
hydrogenosomal iron-sulfur proteins were down-regulated or suppressed, whereas 
actin and lactate dehydrogenase were up-regulated in iron-lacking trichomonads (DE 
JESUS et al., 2007). This is a good example for the potential and amenities of 
proteomics in displaying the status of an organism, depending on the environmental 
conditions, which will also play a role in this study. 
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1.5     Aims of the study 
 
The overall aim of this study was to investigate the mode of action of pentamycin 
against T. vaginalis via microscopic and proteomic methods. Four differently 
metronidazole-sensitive strains of T. vaginalis were used: ATCC 50138 
(metronidazole-resistant), TV2 and ATCC 30236 (both normally metronidazole-
sensitive), and ATCC 30001 (highly metronidazole-sensitive). In a preliminary study, 
pentamycin of less purity (28%) had been shown to be generelly effective against all 
these strains. 
 
First, it was aimed to investigate the effectivity under resistancy stress via 
establishing a long-term drug treatment with sublethal concentrations for six months. 
 
Second, it was aimed to establish a dose-effect-relationship of trichomonads exposed 
to pentamycin and to look whether differently metronidazole-sensitive strains show 
different sensitivities to the treatment with pentamycin. 
 
Third, it was aimed to investigate the mechanism of action with a focus on the effects 
on the protein level. Protein composition pre and post treatment was compared. It 
should be evaluated whether treatment alters the protein composition and if 
trichomonad cells respond to treatment and in which way. Additionally, trichomonads 
in long-term treatment were analysed by this way and compared at different stages of 
resistance by the protein profile to monitor their stage of resistance and to look for a 
correlation between resistance development and altering protein profile. 
 
In a parallel study the mode of action of pentamycin on the DNA level was 
investigated. Here, the genetic regulation pre- and post-treatment was monitored by 
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the establishment of cDNA libraries and comparing corresponding RNA profiles. 
(Michael Syrowatka, in preparation). 
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2 Material and Methods 
 
2.1 Strains 
 
Four strains of Trichomonas vaginalis, differently susceptible to metronidazole, were 
used in this study: ATCC 30001 (highly susceptible), ATCC 30326, TV2 (both 
normally susceptible) and ATCC 50138 (resistant). First, all experiments were 
performed with two strains, ATCC 30001 and TV2. For the last six months, also the 
other two strains were included in the study.  
 
 
2.2 Cultivation of Trichomonas vaginalis 
 
Trichomonas vaginalis was cultured axenically at 37°C in prewarmed modified TYM 
medium (CLARK & DIAMOND, 2002) containing 10% heat-inactivated horse-serum, 3% 
Diamond Vitamin Tween 80 Solution (40x), and 500 U/ml penicillin in 42 ml culture 
flasks under microaerobic conditions (filled up to 40 ml). Medium was changed every 
2–3 days, depending on growth of the trichomonads. 
 
For standard incubation, 100 µl were transferred into 40 ml medium and incubated 
again for 2–3 days at 37°C. When it was necessary to obtain accrued cells within a 
shorter time, the culture was discarded and filled up again with fresh medium to 40 
ml. For growth reduction and inhibition of reproduction, the cultures were incubated at 
30°C or at room temperature. When growth was poor or cells were impaired/inhibited 
after thawing, respectively, medium was discarded and filled up with fresh medium. 
When the cells have recreated a few days later, the normal medium changing 
procedure was applied as described above. TYM medium was made freshly once a 
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week and stored in the fridge at 4°C. Before use, it was prewarmed at 37°C in a 
waterbath. 
  
For cryopreservation, cells were centrifugated at 700 g, afterwards the pellets were 
suspended in 1.8 ml Cell Freezing Medium-DMSO, pipetted into Cryopreservation 
Tubes and stored at -85°C. For storage longer than two weeks, the tubes were 
transferred into a Liquid Nitrogen Deep Freezer. 
 
For a side experiment dealing with the influence of temperature on the susceptibility 
to pentamycin (see 3.1), the cultures were split and incubated at 20°C, 26°C and 
37°C after treating with 1, 2, and 3 µg/ml pentamycin, respectively. 
 
Additionally, 0.025% ammonium ferric (III) citrate was added to TYM medium and 
when it was obvious that the iron-dependent enzyme PFOR was depleted due to lack 
of iron, as described in 3.5.4 and 4.3.3. To incubate the parasites with this 
supplement, 2.5 ml of a stock solution (10 mg/ml) were added to 1 litre of TYM 
medium. 
 
 
2.3 Preparation of drugs 
 
For each of the applied drugs (pentamycin, amphotericin B, metronidazole) a stock 
solution of 10 mg/ml, dissolved in DMSO, was prepared. DMSO is the solvent of 
choice because it alleviates the penetration of the drug through the cell membrane as 
well as it has excellent solvent properties. In small dose rates it may stimulate the cell 
growth, however, in amounts over 10% it has an inhibiting and toxic effect on cells 
(JACOB, 1985). Working solutions were made by diluting the stock solution 1:10 in 
TYM medium. 
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2.4 Treatment of trichomonads  
 
Pentamycin in DMSO as well as the other solutions of drugs were pipetted directly 
into the liquid cell culture. The flask was inverted slightly for several times or shaked 
mildly on the rocker to allow a constant reallocation of the drug solvent. It was worked 
with various doses, depending on the experiment and the application. 
 
For the blank test, 1 µg/ml of pentamycin was added to a cell culture, fully adnated 
with trichomonads (see 3.1, fig. 4). For the experiments dealing with the correlations 
between cell density and applied doses, various concentrations (0.5, 1, 2, 3, 5, 10, 20 
and 50 µg/ml) were added and incubated for 1h (see 3.2, fig. 10).  
 
To prove the obviously directly related correlation of various doses of pentamycin to 
the total cell number, an assay using an empiric scale was performed. These scale 
was consulted to evaluate the vitality of the cells, whereby “5” means optimal vitality, 
“4” means vital cells with impaired motility, “3” means cells that are impaired in their 
vitality and motility moderately, “2” means cells that are impaired severly including 
lysed cells, “1” means only a few living cells are remaining and “0” means minimal 
vitality or EC100. Four cell densities were used (10
6, 105, 104, 103 cells/ml), treated 
with pentamycin in various doses, and observed under the microscope for their 
vitality in periodic time intervals.  
 
The first assay was performed with one 106 cells/ml, treated with 0.5, 1, 1.5, 2, and 
2.5 µg/ml of pentamycin (Fig. 11). Then, a lower cell number (105 cells/ml) and 
another strain were used (Fig. 12). The following assays were performed with two 
strains, four cell densities (106, 105, 104, 103 cells/ml) and three concentrations of 
pentamycin (1, 2.5, and 5 µg/ml). The cultures were inspected after five minutes, 
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subsequently in an interval of 15 minutes and after one hour in an interval of 30 
minutes (Fig. 13–15). Preparations for the microtiter assays were performed as 
described in 2.10. 
 
 
2.5 Staining with Giemsa stain 
 
A slide was coated with a drop of cell culture and dried for one hour at 37°C. Giemsa 
azur-eosin-methylenblue solution of 1:9 dilution was prepared after Weise (pH 7.2). 
Briefly, 5 ml Giemsa and 45 ml phosphate buffer solution were mixed, the slides were 
fixed in methanol for two minutes, dried and stained in the solution for 30 minutes. 
After staining, the slides were dried and photographed under a phase-contrast 
microscope. 
 
 
2.6 Staining with Trypan Blue stain 
 
100 µl of Trypan blue solution (0.4%) were mixed with 100 µl of cell suspension and 
incubated for approximately 5 minutes. The solution was observed under a 
microscope in a Fuchs-Rosenthal hemocytometer. Blue cells were assigned as dead, 
unstained cells were assigned as alive or inhibited when immotile. 
 
 
2.7 Counting cells with the Fuchs-Rosenthal Hemacytometer 
 
This counting chamber has 4x4 large squares with a side length of each 1 mm. Each 
large square has 16 small squares which are the ones to count, so there are a total of 
256 countable squares. 4 large squares were determined by counting the cell 
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number of 4 small squares in a diagonal way and multiply it with four which makes 
the cell number of 3 µl. To get the cell number of 1 ml this value had to be multiplied 
with 333.3. 
 
For determination of the inhibitory concentration of pentamycin, all immotile cells 
were counted and correlated to the total cell number. For determination of the 
effective concentration, only the dead – blue stained – cells were counted and 
correlated to the total cell number. 
 
 
2.8 1D SDS-PAGE 
 
The 1D SDS-PAGE (LAEMMLI, 1970) is a method to separate previously denatured 
proteins by their molecular mass and to make them visible by protein staining 
methods, mostly by Coomassie or silver staining. In this study, this method was used 
to compare protein profiles between pentamycin treated cultures of T. vaginalis and 
untreated cultures, and was performed in 5% stacking gels and 12% resolving gels 
(SAMBROOK et al., 2001) with the Bio-Rad system. 
 
Cell cultures were treated with various doses of pentamycin and incubated for two 
hours. The time of incubation was set to one hour. For the first experiments, (see 
3.4.1, fig. 28–33) low doses of 0.5 and 1 µg/ml were chosen because the 
trichomonads should show discomfort in their morphology and motility, but should 
also be still vital. Higher doses like 2, 7, and 10 µg/ml were chosen to show the 
severity of the effect on protein diminishment (see 3.4.1, fig. 34–36). In this case, a 
majority of the cells were dead at the time of analysis. 
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2.8.1 Sample preparation 
 
Cells were grown to a cell density of around 1x106 cells/ml, so that the culture 
medium was adnated densely with vital trichomonads. The cells were harvested by 
centrifugation at 700 g for 5 minutes. Pellets were washed in 1xPBS by the same 
centrifugation procedure, followed by another washing step with dH2O to remove 
residual serum proteins from the culture medium and salts from PBS. The 
supernatant was discarded and 400 µl of dH2O were added to the pellets, mixed and 
transferred into a 1.5 ml Eppendorf tube. The rest of the volume was filled up with 
12.5% TCA in 90% acetone (-20°C) to precipitate the proteins. The time of 
precipitation was set from 1h to over night at -20°C.  
 
Precipitated proteins were centrifuged at 13.300 g for 1 minute at 4°C, and washed 
twice with 90% ice-cold acetone at 13.300 g and 4°C for 5 minutes. These washing 
steps were essential to remove disturbing TCA. After washing, the pellets were air 
dried for at least 10 minutes until the residual acetone was gone and resuspended in 
an appropriate amount of lysis buffer (7M urea, 2M thiourea, 4% CHAPS, 1% DTT, 
1% BioLyte; stored at -80°C). Small pellets were suspended in 100 to 300 µl, large 
pellets in 500 to 1000 µl, intermediate pellets in a range from 150 to 300 µl. 
Resolubilization was performed on a mild shaker for at least 2 hours or over night. 
Generally, temperature must not rise above 30°C, otherwise urea will lead to 
carbamylation of proteins. The neutral chaotropic agent urea denatures proteins, 
avoids hydrophobic interactions and provides their solubility, which can be increased  
by thiourea. The non-ionic detergens CHAPS avoids formation of aggregates and 
dithiothreitol reduces disulfide bonds of proteins. After resolubilization, a step of at 
least 1h of centrifugation at 13.300 g was performed to remove residual nucleic acids 
or debris.  
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Before loading onto the gel, 10 µl of SDS-sample-buffer (20% (v/v) glycerol, 4% (w/v) 
SDS, 125 mM Tris-HCl pH 6.8, 0.02% (w/v) bromophenol blue, 2% ß-
mercaptoethanol) were added to 10 µl of sample, which leads to denaturation of 
proteins after 5 minutes at 95°C. SDS degrades the native protein into its secondary, 
or even, primary structure, ß-mercaptoethanol breaks up the disulfide bonds, 
whereas bromophenol blue works as a marker for the following electrophoresis 
(LEITSCH et al, 2005).   
  
2.8.2   Gel preparation 
 
Complementary glass plates of 1 mm and 0.75 mm thickness, respectively, were 
assembled into a clamp. The gels were prepared in 50 ml centrifugation tubes. 10 ml 
of a 12% resolving gel were made as following: 3.3 ml dH2O, 2.5 ml 4x lower Tris 
buffer pH 8.8 (containing 20% (w/v) SDS), 4.2 ml acrylamide (30%, 
w/v)/bisacrylamide (0.8%, w/v), 50 µl 10% (w/v) APS, 5 µl TEMED.  
 
10% APS (w/v) was prepared freshly prior to each set up and used for maximum a 
week. After adding APS and TEMED, the liquid was mixed by inverting, and poured 
into the gap between the two glass plates rapidly due to the properties of APS as 
initiatior of the polymerization of acrylamide to polyacrylamide, and TEMED as 
catalyzator of the reaction. When the plates were filled about 4/5 with the resolving 
gel, a layer of isopropanol was pippeted onto the surface to get it smooth, according 
to the process of polymerisation. The time of polymerisation was around from 15 to 
30 minutes.  
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5 ml of a 5% stacking gel were made as following: 3 ml dH2O, 1.25 ml upper Tris 
buffer pH 6.8 (containing 20% (w/v) SDS), 800 µl acrylamide (30%, w/v)/ 
bisacrylamide (0.8%, w/v), 40 µl 10% (w/v) APS, 5 µl TEMED. 
 
2.8.3  Electrophoresis 
 
After polymerization of the resolving gel, isopropanol was poured off and the stacking 
gel was pipetted into the residual space above the resolving gel. Appropriate combs 
of 1 mm thickness were put into the stacking gel and removed when the gel has 
polymerized. Subsequently, the glass plates with the gel were put into the special 
clamp holder of the BioRad Mini-Protean system, fixed into the tray and filled up with 
1x running buffer (25 mM Tris-HCl, 200 mM glycine, 0.1 % SDS (w/v)). 10 µl of the 
samples and 10 µl of Prestained Protein Marker MW (PeqLab) were loaded into each 
slot and electrophoresis was started. The proteins migrated at low voltage and 
amperage (22 mA, 80 V) for the first 20 minutes through the macropore stacking gel 
to focus them on a line, then the voltage was turned up to 150 V for the rest of the 
time. The migration of the proteins through the resolving gel lasted from 2 to 3 hours. 
 
2.8.4  Staining with Coomassie stain 
 
After finishing, the gels were stained with Coomassie Brilliant Blue R-250 solution 
(45% dH2O, 10% acetic acid (v/v), 45% methanol (v/v), 0.8% Coomassie Coomassie 
Brilliant Blue R-250 (w/v)) at least for 1 hour and destained with destaining solution 
(70% dH2O, 10% acetic acid (v/v), 20% methanol (v/v)) as long as necessary. After 
destaining, the gels were laid into water to remove residual methanol. When finished, 
the gels were shrinkwrapped and photographed.  
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2.8.5  Protein diminishment assay  
 
This was applied to look for proteins that had migrated from inside the cell into the 
extracellular medium and to compare the protein profiles of cells and supernatant, 
respectively. The cultures were centrifuged at 700 g for harvesting, subsequently the 
cell pellets were resuspended in 1 ml of PBS and incubated with 0, 2, 5, and 10 
µg/ml pentamycin, respectively, for 30 minutes under mild shaking. Subsequently, 
the suspension was centrifuged for 30 seconds at 3.000 g, the supernatant was 
taken off until 200 µl from the bottom and centrifugated again. The proteins of the 
supernatant as well as the cell pellet fraction were precipitated and analysed by 1D 
SDS-PAGE as described previously. The experiment was repeated two times with 
each strain. 
 
 
2.9 2D SDS-PAGE 
 
The two-dimensional SDS polyacrylamide gelelectrophoresis was also performed 
with the BioRad System after GÖRG et al. (2007), with modifications. This technique 
allows the visualisiation of proteins after their separation by their isolelectric point in 
the first dimension (“horizontal separation”) and by their molecular mass in the 
second dimension (“vertical separation”). Mainly, it was performed to compare the 
protein profiles of wildtypes and those being in long-term treatment with pentamycin, 
assuming to detect differences that might concern metabolic pathways correlated 
with resistance establishment. Wildtypes and partial resistant trichomonads were 
analysed for a time span of 4 months, covering different time stages of long-term 
treatment (see 3.5.4, fig. 50–54).  
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Because the results led to the assumption that addition of pentamycin shortly before 
may affect the protein profile by its mode of action (see 3.4), which might be a false 
positive conclusion for the results in this study, a final experiment with 4 approaches 
was performed. It was attached importance to eliminate the proteolysis factor by not 
treating the R-strains (term used for adapted strains) up from 2 days before 
harvesting. The study design was defined as comparing untreated cells with one-time 
treated cells (2.5 µg/ml, 2 hours incubation) as well as comparing R-strains, 
untreated before harvesting, with R-strains, immediately treated before harvesting 
(2.5 µg/ml, 2 hours incubation) (Fig. 55). So it should have been possible to monitor 
and distinguish proteolysis effects from such ones that have developed from a 
possible resistance mechanism. 
 
Due to the varying running times of the gels, caused by various technical problems, it 
was not possible to analyse the 2D SDS-PAGE protein spots via the Melanie 
software package. Instead, the spots were compared and identified manually with the 
support of David Leitsch. 
 
2.9.1  Sample preparation 
 
Cell harvesting, protein precipitation and resolubilization were identical as described 
in 2.8.1. A necessary step before rehydration was measuring the protein 
concentration. For silver staining, 50–100 µg protein was required, for Coomassie 
staining 500–1000 µg. Protein concentrations were measured by Bradford-Assay: 
800 µl dH2O + 3 µl sample + 200 µl Bradford solution were pipetted into a cuvette (for 
the blank control 3 µl of lysis buffer instead of sample). Extinction was measured 
photometric at a wavelength of 595 nm and divided by the calibration factor 0.14, 
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which results in the concentration per volume. Optimal concentration was between 5–
10 mg/ml protein. The respective sample volume was filled up to 400 µl with lysis 
buffer and spiked with a tiny drop of bromophenol blue to make it visible as pale blue.  
 
2.9.2  First dimension – Isoelectric focussing 
 
The first dimension was performed with the BioRad Protean IEF cell and 17 mm 
strips with immobilized pH gradient (IPG), which contain a series of chemically well 
defined acrylamide derivates (BJELLQVIST et al., 1982). In the current study, buffers 
with pK values between pK 3 and 10 were used. Prior to IEF, the IPG strips had to be 
rehydrated to their original thickness of 0.5 mm with a rehydration buffer that is 
identical to the lysis buffer. During the IEF, differently charged proteins migrate 
through the electrical field until they reach their specific isoelectrical point (IEP) where 
they become neutral and stop to migrate.  
 
First, a sample volume of 400 µl was loaded into each slot, subsequently the IPG 
strips were added with the gel side downwards, and coated with 2.5 ml of mineral oil 
to avoid volatilization.  
 
The programme was set as following and run overnight: Rehydration 50 mV for 12 
hours, 150 V for 1h (rapid slope), 300 V for 1h (rapid slope), 2000 V for 1h (linear 
slope), 5000 V for 2h (linear slope) and 10.000 V for 6h (rapid slope). The last step 
was shortened to 3h when working with low sample loads (e.g. for subsequent silver 
staining). When finished, voltage dropped down to 500 V.  
 
 
 
MATERIAL AND METHODS 
 
61 
2.9.3  Gel preparation 
 
For the following steps, resolution buffer and equibrilation buffer were prepared. The 
resolution buffer contained 1.5 M Tris-Base, 0.4% SDS and was filled up with dH2O 
to 500 ml and adjusted to pH 8.6 with 20% HCl. The equibrilation buffer contained 6M  
urea, 30% glycerol, 2% SDS, 16.7 ml resolution buffer and was filled up with dH2O to 
500 ml. Two 12.5% resolving gels were prepared in 100 ml as following: 30 ml dH2O, 
5 ml glycerol, 25 ml resolution buffer, 40 ml acrylamide (30%,w/v)/bisacrylamide 
(0.8%,w/v), 300 µl 10% (w/v) APS and 40 µl TEMED. The gel was casted between 
the glass plates as described above. The time of polymerisation was about 2h. 
 
2.9.4  Equibrilation 
 
Equibrilation consisted of two steps: Reduction of cysteine groups with dithiothreitol 
(DTT) and alkylation of reduced cysteines with iodacetamide (IAA). This is necessary 
to obtain clear spots. The IPG strips were placed into an equibrilation tray, washed 
with dH2O, and incubated in 10 ml 1% DTT equibrilation buffer for 15 min and in 10 
ml 4% IAA equibrilation buffer for 15 min under mild shaking.  
 
2.9.5  Second dimension – Electrophoresis 
 
First, a 0.8% agarose solution in resolution buffer was prepared, boiled in the 
microwave, spiked with a drop of bromophenol blue and cooled down in a waterbath 
to 37°C. The IPG strips were washed with dH2O and put onto the top of the resolving 
gel. Then, a layer of cooled down agarose was added and after a few minutes of 
polymerization, the two gel plates were put into the 2D SDS-PAGE tank, filled with 2l 
of running buffer. The tank was connected with the power supply and put into the 
MATERIAL AND METHODS 
 
62 
fridge where it ran overnight with an initial amperage of 15-20 mA. The voltage 
increased by progressing running time, which was around 15 hours.  
 
2.9.6  Staining with Coomassie stain 
 
This step was identical to the one described in 2.8.4. 
 
2.9.7  Staining with Silver stain 
 
This step followed the protocol after BLUM et al. (1987): Briefly, gels were fixed for 1h 
in 40% (v/v) ethanol and 10% (v/v) acetic acid. Acetic acid was removed with 30% 
ethanol for 2x20 minutes, ethanol was removed with dH2O for 1x30 minutes or 2x5 
minutes. A solution of 0.02% (w/w) sodium-thiosulfate was added for 20 seconds of 
sensitizing and removed with dH2O for 3x20 seconds. Subsequently, the gels were 
incubated with a silver nitrate solution (2 g of silver nitrate + 200 µl of 37% 
formaldehyde in one litre) for ten minutes before washing with dH2O for 3x20 
seconds. The developing solution contained sodium carbonate (30 g of sodium 
carbonate + 500 µl of 37% formaldehyde in one litre) and was carried out as long as 
necessary for the reduction of silver. Finally, a stop solution with 0.5% glycine was 
added and incubated for ten minutes. When finished, the gels were shrinkwrapped, 
scanned, and photographed. 
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2.10  Microtiter assays 
 
To evaluate the doses of pentamycin, necessary to kill or to inhibit a certain 
percentage of cells, microtiter assays were performed in 24-well plates with 2.5 ml 
volume per well. First, cell cultures at a countable density of approximately 1x106 
cells/ml were pipetted into the wells and incubated at 37°C for about 15 minutes to 
give them recovery from previous pipetting stress.  
 
Subsequently, test series with eight dilutions of 94% (Ch.-B. C-017084-PRS-03) 
pentamycin (0.5, 1, 2, 3, 4, 5, 10, and 15 µg/ml) were run including two positive and 
two negative controls. EC and IC data were used as an effective concentration of 20 
µg/ml pentamycin (28%) (Ch.-B. 020) and as a less effective concentration of 50 
µg/ml for metronidazole, referring to “Comparative studies on the activity and mode 
of action of pentamycin on Trichomonas vaginalis, Report G40/07”.  
 
These concentrations were chosen to have an visible effect on the cells without killing 
them entirely. As negative controls, cells in culture medium without any addition 
(blank sample) and with the highest respective concentration of DMSO used in the 
drug supplements, were applied.  
 
For the experiments on cross resistance, the following dilutions of amphotericin B 
were used: 10, 50, 100, 150, 200, 300, 400, and 500 µg/ml. The wells were counted 
after one, three and six hours of treatment with a phase contrast microscope and a 
cell counter. Positive and negative controls were applied as described above.  
 
All four strains were used and each strain was counted in parallel triplicates. IC50/90s 
(inhibitory concentrations with 50% and 90%, respectively, of the cells immotile and 
inhibited) and EC50/90s (effective concentrations with 50% and 90%, respectively, of 
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the cells dead) were calculated by SPSS with linear regression/probit analysis. The 
results were expressed as diagrams and arithmetic means with standard deviations.  
Furthermore, the standard error of arithmetic means as well as the level of 
significance (=error probability; significance p <= 5%, high significant p <=1%, 
highest significant p <=0.1%) was calculated by SPSS analysis of variance with 
repeated measurements.  
 
In a side experiment, the influence of the temperature on susceptibility was 
investigated. For this purpose, two strains (ATCC 30236 and ATCC 50138) were 
incubated with 1, 2, 3, and 4 µg/ml of pentamycin at temperatures of 20°C, 26°C, and 
37°C for 1h. Subsequently, the amount of vital cells was counted.  
 
 
2.11 Long-term treatment  
 
In the first four months from June to September 2009, the strains were treated every 
2–3 days with rising concentrations of 0.5 µg/ml pentamycin dissolved in DMSO. 
Trichomonads responded to the treatment with 100% lethality at various stages. A 
few cells seemed not to be affected by the drug, as they were inside a cell cluster, 
and led to a proliferated cell culture again. When it was obvious that this method 
results in dead cells at higher doses – probably due to the relative large intervals of 
incubation time and concentration – the approach was changed: At least once, but at 
maximum three times a day, a sublethal amount of pentamycin between 0.25 µg/ml 
and 3.0 µg/ml was added to the cultures, depending on cell density and vitality of 
trichomonads. Consecutively, the dose was increased by 0.1 µg/ml, respectively. At 
good vitality, the applied dose was increased by 0.2–0.3 µg/ml.  
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After 4 and 5 months of continuous, daily addition of sublethal doses, respectively, 
strain ATCC 50138 (metronidazole-resistant) was applied to check the susceptibility 
to pentamycin in comparison to wildtypes. For this purpose, microtiter assays with 
Trypan blue stain, as described in 2.5 and 2.10, were performed (see results 3.5.2).  
 
Cross resistance to amphotericin B was also investigated, due to the similar action 
mechanism of these polyenes (ANDREOLI & MONAHAN, 1968; HSUCHEN & FEINGOLD, 
1973). For this purpose, microtiter assays as described in 2.4 and 2.10, with seven 
concentrations of amphotericin B (10, 50, 100, 150, 200, 300, and 400 µg/ml) were 
performed. Two strains (ATCC 30236, TV2) were counted after four months of 
resistance treatment (see results 3.5.3).  
 
 
2.12 Lactate dehydrogenase enzyme activity assay 
 
Lactate dehydrogenase (LDH) reduces pyruvate to lactate and oxidizes NAD+ to 
NADH/H+. By measuring the turnover rate of NAD+ in cells, the quantity of LDH can 
be determined . 
 
The following assay (after LEITSCH et. al, 2010) was performed subsequently to the 
last 2D SDS-PAGE experiment, to follow the idea of an obviously altered expression 
of LDH in R-strains: After harvesting and centrifuging at 700 g for 5 min, the cells 
were washed twice with PBS and dH2O. 800 µl SM-buffer (250 mM sucrose + 10 mM 
MOPS (3-N-morpholino-propanesulfonic acid)) was added to the pellets and mixed. 
The suspension was transferred into a slotter, pounded on ice for 30 times and 
poured into an Eppendorf tube. Then it was centrifuged at 20.000 g for ten minutes at 
10°C. The supernatant was taken off and was measured for protein concentration 
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after Bradford as described in 2.9.1. The enzyme activity assay was prepared with 
100 mM NADH-solution and reaction buffer (100 mM Tris-HCl, pH 7.5; 0.2 mM 
NADH; 1mM EDTA; 2mM pyruvate) and started with 5 µg protein equivalent, mixed 
with 1 ml of reaction buffer. The measurement was performed at 340 nm and 25°C 
by noticing the photometric value every 30 seconds which corresponds with the 
turnover rate of the substrate.  
 
 
2.13   Cell permeability assay 
 
This assay was performed according to the study of PALACIOS AND SERRANO (1978) 
that demonstrated the effect of polyene antibiotics on the proton permeability of the 
cell. In this case, a changing pH of the extracellular environment after administration 
of low, sublethal drug doses may have its reason in the formation of tiny membrane 
pores that let pass through small ions like H+ and K+. The described methods were 
simplified by disclaiming the addition of 2-deoxyglucose. Measurements were 
performed in 12-well microtiter plates, each containing 5 ml of suspension with 0.25 
µg/ml, 0.5 µg/ml, 1 µg/ml, 2 µg/ml, 3 µg/ml, 5 µg/ml, 10 µg/ml of pentamycin, 
respectively. As negative control pure cell culture in TYM medium was used. pH 
values were measured before the addition of pentamycin and 30 minutes, 1, 3, and 6 
hours, subsequently.  
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2.14   Nile Red stain and fluorescence microscopy 
 
Nile Red (9-diethylamino-5H-benzo [α] phenoxazine-5-one) can be used as a 
fluorescent dye in order to monitor properties of the cell membrane. For this study, a 
protocol by KIERNAN (2008) was adapted and applied as following: A stock solution 
was prepared by dissolving 0.5 mg Nile Red in 1 ml of acetone. To obtain a working 
solution, 0.05 ml of the stock solution was added to 50 ml of a 75:25 glycerol-water 
mixture. A drop this solution was put on a glass slide, mixed with a drop of cell 
suspension, and dried at 37°C. The stained cells were observed under a 
fluorescence microscope with a UV filter at 340 nm. 
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3   Results 
 
 
3.1   Morphology of pentamycin-treated trichomonads 
 
After treatment, cells appeared impaired, showed diminished motility and exuded 
severe discomfort. Some cells also appeared as rounded and/or enlarged, and were 
even lysed or in the process of lysation. The cells appeared more harmed with 
increasing time of incubation. For a preliminary test, a dose of 10 µg/ml was added, 
and after 10 minutes a distinctive effect with a large amount of lysed cells was 
observable. For the following analyses, smaller doses were used. Fig. 3–4 show the 
result of the consecutive treatment with addition of 1 µg/ml pentamycin incubated for 
90 mintues .   
 
The comparison of treated and untreated cells indicated an increase of cell damage 
with higher doses (1, 3, 10 µg/ml), leading to lysis finally at 10 µg/ml. It was 
noticeable that the cells assembled in dense batches, and stained particles – 
probably flown out cell content – appeared in the environment of the cells. At 10 
µg/ml, nearly all cells seemed to be completely lysed (Fig. 5–8, Giemsa stain).  
 
A further observation, dealing on the susceptibility to pentamycin, was the influence 
of temperature. At a lower temperature of 26°C, trichomonads were less motile and 
vital but also seemed to be less susceptible to the drug. Especially at concentrations 
of 3 and 4 µg/ml, the difference was considerable between cells cultivated at 26°C 
and 37°C. Whereas there were 55% (3 µg/ml) and 35% of vital cells (4 µg/ml) at 
26°C, there were 15% (3 µg/ml) and less than 5% (4 µg/ml) of vital cells observable 
at 37°C within the same incubation time (Fig. 9).  
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This effect was reversible: When incubated at 37°C again, the trichomonads 
regained back their motility and also their susceptibility to pentamycin. After 3 hours, 
it could be observed that not only the motility has increased, but also the amount of 
lysed cells.  
 
 
 
 
Fig. 3:  Untreated, vital and motile trichomonads (40x magnified, ATCC 30001). 
 
 
Fig. 4: Trichomonads, treated with 1 µg/ml, after 90 min of incubation (40x magnified). 
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Fig. 5: Untreated trophozoite (during mitosis, two nuclei), Giemsa stained (ATCC 30001). 
 
Fig. 6: Trophozoites treated with 1 µg/ml pentamycin after 2h of incubation. 
 
 
Fig. 7: Trophozoites treated with 3 µg/ml pentamycin after 2h of incubation. 
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Fig. 8: Trophozoites treated with 10 µg/ml pentamycin after 2h of incubation. 
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Fig. 9: ATCC 50138, cultivated at 26°C and 37°C, and incubated for 1h. 
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3.2   Correlation between cell density and dose rate 
 
 
Cells treated with doses of 10 µg/ml and above were lysed in 100% of cases, 
whereas at lower doses a smaller amount of cells was affected. The cells that were 
still vital appeared impaired, round or amoeboid shaped, and with shrugging 
movements. 1h after treatment, nearly all cells were viable and motile at 0 and 0.5 
µg/ml. From 1 to 3 µg/ml, the amount of round and lytic cells was increasing. At 5 
µg/ml, only a few single cells were still motile but severely impaired. At 10 µg/ml, all 
cells were immotile and lysed. Interestingly, granula-like particles appeared around 
the lysed cells additionally, however, only after an overdose of  50 µg/ml (Fig. 10). 
 
 
Blank test for the microtiter assays 
 
An empiric scale was set up to mark the appearance of treated trichomonads: 5 (all 
cells are vital and motile), 4 (mostly vital with impaired motility of a few cells), 3 (vital 
but impaired with a few round forms and <50% lysed cells), 2 (severely impaired, 
round forms, >50% lysed cells), 1 (nearly all cells lysed with a few motile/viable cells), 
0 (100% lysed cells).  The estimation of the vitality after treatment with various doses, 
respectively, showed “4” after 0.5 µg/ml and “3” after 1 and 1.5 µg/ml. After 2 and 2.5 
µg/ml it showed “1” after 10 min, and below “1” after 30 and 60 minutes (Fig. 11).  
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0 µg/ml                                                                      0.5µg/ml                                            
  
 1 µg/ml                                                                      2 µg/ml                                              
 
 3 µg/ml                                                                     5 µg/ml  
 
10 µg/ml                                                                    50 µg/ml 
Fig. 10: Process of cytolysis at 1h after treatment with pentamycin (94%). Note: while living cells were 
swimming around actively, dead cells sedimented on the bottom of the flasks. 
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Fig. 11: ATCC 30001 (106 cells/ml), treated with various doses of pentamycin. 
 
 
 
After treating 105 cells/ml, the condition of the cells was worse than previously: The 
estimation of the vitality showed “0” after treatment with 0.5 µg/ml and 3h of 
incubation. All higher doses than 0.5 µg/ml resulted in 100% dead cells after 30 
minutes. Up from 1 µg/ml, it showed “1” and below after 5 min, at 0.5 µg/ml between 
“2” and “3” after 5 min and “1” after 30 min (Fig. 12). A stronger effect than in fig. 11 
can be stated, most probably due to a smaller number of examined cells. 
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Fig. 12: Strain TV2 (105 cells/ml), treated with various doses of pentamycin. 
 
 
 
The following diagrams (Fig. 13–15) demonstrate that lower cell densities (103 and 
104 cells/ml) undergo a faster decline of their vitality than higher cell densities (105 
and 106 cells/ml) when exposed to pentamycin. The assay was performed with ATCC 
30001 (highly metronidazole-sensitive) and TV2 (metronidazole-sensitive) (data of 
TV2 not shown), and both strains showed similar reactions to the treatment. They 
were severely affected and inhibited at 2.5 µg/ml after 15 min (Fig. 14), and at 5 
µg/ml after 5 min (Fig. 15). A concentration of 1 µg/ml was obviously too low to be 
effective and led to more (low cell densities) or less (high cell densities) damage. The 
longer the incubation time and the higher the applied dose, the stronger the harming 
effect was. Interestingly, it was also observable that 90 minutes after treatment with 1 
µg/ml, cells at a density of 106 cells/ml seemed to regenerate (Fig. 13). Althogether, 
there is a positive correlation between cell density and the dose rate of pentamycin. 
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Fig. 13: 103 to 106 cells/ml (ATCC 30001) were treated with 1 µg/ml and observed for their vitality in 
periodic time intervals. 
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Fig. 14: 103 to 106 cells/ml (ATCC 30001) were treated with 2.5 µg/ml and observed for their vitality in 
periodic time intervals. 
 
RESULTS 
 
77 
Vitality after treatment
0
1
2
3
4
5
6
0 5 15 30 45 60 90 120 150 180
minincubation time
v
it
a
li
ty
10^3 10^4 10^5 10^6
Fig. 15: 103 to 106 cells/ml (ATCC 30001) were treated with 15 µg/ml and observed for their vitality in 
periodic time intervals. 
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3.3   Effective and inhibitory concentrations (EC50/90,  IC50/90) of 
pentamycin on four T. vaginalis strains 
 
 
ATCC 30001 (highly metronidazole-sensitive strain) 
 
 
Fig. 16–18 display the relative motility and vitality of this strain after treating with 
various doses of pentamycin and incubated for 1, 3, and 6 hours, respectively. It 
could be shown that the amount of motile and vital cells is decreasing with higher 
doses of pentamycin as well as with longer incubation time.  
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Fig. 16: Motility and vitality of strain ATCC 30001 after 1h of treatment with pentamycin. 
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Fig. 17: Motility and vitality of strain ATCC 30001 after 3h of treatment with pentamycin. 
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Fig. 18: Motility and vitality of strain ATCC 30001 after 6h of treatment with pentamycin. 
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Tab 3: EC and IC values (µg/ml) of ATCC 30001 after 1h, 3h, and 6h. 
ATCC 30001 1h 3h 6h 
IC50 0,922 0,774 0,639 
IC90 3,369 2,450 2,010 
EC50 2,210 1,620 1,280 
EC90 6,514 4,616 3,621 
 
 
TV2 (normally metronidazole-sensitive strain) 
 
 
Also in this case, fig. 19–21 display the relative motility and vitality of this strain after 
treating with various doses of pentamycin and incubated for 1, 3, and 6 hours, 
respectively. It could be shown that the amount of motile and vital cells is decreasing 
with higher doses of pentamycin as well as with longer incubation time.  
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Fig. 19: Motility and vitality of strain TV2 after 1h of treatment with pentamycin. 
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Fig. 20: Motility and vitality of strain TV2 after 3h of treatment with pentamycin. 
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Fig. 21: Motility and vitality of strain TV2 after 6h of treatment with pentamycin. 
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Tab 4: EC and IC values (µg/ml) of TV2 after 1h, 3h and 6h. 
TV2 1h 3h 6h 
IC50 1,004 0,887 0,678 
IC90 3,778 2,904 2,362 
EC50 2,169 1,478 1,085 
EC90 6,205 4,481 3,467 
 
 
ATCC 30236 (normally metronidazole-sensitive strain) 
 
 
As before, fig. 22–24 display the relative motility and vitality of this strain, after 
treating with various doses of pentamycin and incubated for 1, 3, and 6 hours, 
respectively. It could be shown that the amount of motile and vital cells is decreasing 
with higher doses of pentamycin as well as with longer incubation time.  
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Fig. 22: Motility and vitality of strain ATCC 30236 after 1h of treatment with pentamycin. 
RESULTS 
 
83 
3h Incubation
0
10
20
30
40
50
60
70
80
90
100
0 0,5 1 2 3 4 5 10 Controls
concentration [µg/ml]
m
o
ti
le
 /
 l
iv
in
g
 c
e
ll
s
 (
%
)
Pentamycin IC
Pentamycin EC
Pentamycin 28% (20µM) IC
Metronidazol (50µM) IC
Pentamycin 28% (20µM) EC
Metronidazol (50µM) EC
 
Fig. 23: Motility and vitality of strain ATCC 30236 after 3h of treatment with pentamycin. 
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Fig. 24: Motility and vitality of strain ATCC 30236 after 6h of treatment with pentamycin. 
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Tab. 5: EC and IC values (µg/ml) of ATCC 30236 after 1h, 3h and 6h. 
ATCC 30236 1h 3h 6h 
IC50 0,869 0,680 0,533 
IC90 2,725 2,081 1,455 
EC50 1,744 1,248 0,913 
EC90 4,909 3,443 2,357 
 
 
ATCC 50138 (metronidazole-resistant strain) 
 
 
Here, fig. 25–27 display the relative motility and vitality of this strain, after treating 
with various concentrations of pentamycin and incubated for 1, 3, and 6 hours, 
respectively. It could be shown that the amount of motile and vital cells is decreasing 
with higher doses of pentamycin as well as with longer incubation time. 
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 Fig. 25: Motility and vitality of strain ATCC 50138 after 1h of treatment with pentamycin. 
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Fig. 26: Motility and vitality of strain ATCC 50138 after 3h of treatment with pentamycin. 
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Fig. 27: Motility and vitality of strain ATCC 50138 after 6h of treatment with pentamycin. 
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Tab. 6: EC and IC values (µg/ml) of ATCC 50138 after 1h, 3h and 6h. 
ATCC 50138 1h 3h 6h 
IC50 1,350 0,941 0,766 
IC90 3,507 2,378 1,856 
EC50 2,620 1,505 1,061 
EC90 5,770 3,568 2,459 
 
 
 
Due to the large number of data, IC50s, IC90s, EC50s, and EC90s of all strains were 
summed up and their arithmetic mean was calculated for a better illustration of these 
results. This should demonstrate the efficacy of pentamycin (94%) (Tab. 7) and the 
low dose required for inhibition and eradication of trichomonads.  
 
In general, all strains showed almost the same susceptibility to pentamycin, though 
not significant but with a distinct tendency. The level of significance was calculated as 
14.1%, which is non-significant (significance p <= 5%) but still a low error-probability 
and  explainable by the large standard deviations between the measurements of the 
respective strains (Tab. 8). Overall standard deviation is 13.59%, the standard error 
of arithmetic means 1.5%. The Levene Test (Tab. 10) shows that the greatest error 
probability is at 1 µg/ml. In both cases, its values are non-significant with 25.4% (IC) 
and 38.6% (EC). Large deviations are also at 0 µg/ml (EC) with 22.8% error 
probability. 
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Tab. 7: Arithmetic means after treatment with pentamycin (94%) 
 
Arithmetic mean of 
µg/ml – all strains 
 
1h 
 
3h 
 
6h 
 
IC50 
 
1,04 
 
0,82 
 
0,65 
IC90 
 
3,35 
 
2,45 
 
1,92 
EC50 
 
2,19 
 
1,46 
 
1,09 
EC90 
 
5,85 
 
4,03 
 
2,98 
 
 
Tab. 8: Significance of consistency between the strains (marked bold). 
Source df (degree of freedom) F Significance 
Constant 
Term 
 
1 
 
284,444 
 
,000 
 
Time 
 
1 
 
52,011 
 
,000 
 
Triplicate 
 
1 
 
3,531 
 
,065 
 
Strain 
 
3 
 
1,886 
 
,141 
 
Tab. 9: Arithmetic means of the sensitivity of strains with standard error. 
Strain 
Arithmetic mean 
(motile/vital cells in %) Standard error 
 
ATCC 30001 
 
34,437 
 
1,531 
 
TV 2 
 
32,284 
 
1,531 
 
ATCC 30236 
 
29,810 
 
1,577 
 
ATCC 50138 
 
34,188 
 
1,531 
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Tab. 10: Levene Test: consistency of error variance (bold: non-significant values). 
  
F 
df1 (degree of 
freedom) 
df2 (sample 
size) Significance 
0 µg/ml IC 8,544 3 67 ,000 
0,5 µg/ml IC 6,860 3 67 ,000 
1 µg/ml IC 1,388 3 67 ,254 
2 µg/ml IC 4,175 3 67 ,009 
3 µg/ml IC 4,121 3 67 ,010 
4 µg/ml IC 4,249 3 67 ,008 
5 µg/ml IC 7,029 3 67 ,000 
10 µg/ml IC 2,941 3 67 ,039 
15 µg/ml IC . 3 67 . 
Pent 20 µg/ml 
IC 
8,071 3 67 ,000 
Metro 50 
µg/ml IC 
3,077 3 67 ,033 
0 µg/ml EC 1,479 3 67 ,228 
0,5 µg/ml EC 5,948 3 67 ,001 
1 µg/ml EC 1,027 3 67 ,386 
2 µg/ml EC 4,300 3 67 ,008 
3 µg/ml EC 5,022 3 67 ,003 
4 µg/ml EC 4,276 3 67 ,008 
5 µg/ml EC 6,187 3 67 ,001 
10 µg/ml EC 7,922 3 67 ,000 
15 µg/ml EC . 3 67 . 
Pent 20 µg/ml 
EC 
3,636 3 67 ,017 
Metro 50 
µg/ml EC 
1,445 3 67 ,237 
 
RESULTS 
 
89 
Summing up these results, a positive correlation of drug dose, incubation time and 
amount of impaired and lysed cells was measurable. 0.5 µg/ml pentamycin per 106 
cells/ml is a sublethal, low dose that leads largely to discomfort and impairment and 
to a percentage of average 10% of dead cells. However, affected and though viable 
trichomonads are able to regenerate within 24 hours. 1 µg/ml is a critical treshold 
concentration as there were no viable cells observable after 24h of treatment, and it 
can be constituted as minimal lethal concentration (MLC). Up from 2 to 4 µg/ml, a 
serious effectiveness was observable as 30% and more cells could be killed within 
1h. To kill 50% of trichomonads within 1h (EC50), a dose of 2.2 µg/ml would be 
necessary. 
 
At 5 µg/ml, which can be assigned as a high dose, 100% of cells were lysed in the 
best case and 90% in the worst case. At 15 µg/ml, 100% of lysed cells within 1h can 
be stated. Treated cell cultures included impaired trichomonads after treatment with 
low, sublethal concentrations, showing uncoordinated, rotary movements and a few 
rounded, immotile forms. These forms appeared at low, sublethal doses. The higher 
the applied dose, the less of the round forms and more completely lysed cells were 
observable. At a dose of 10 µg/ml, nearly all cells were lysed. At a dose of 50 µg/ml, 
which is more than three times higher than the dose needed for an EC100 within 1h, 
particles similar to granula were visible around the lysed cells. 
 
At 1h post treatment, IC50s of the respective strains were between 0.86–1.35 µg/ml, 
IC90s between 2.45–3.78 µg/ml. EC50s were between 1.74–2.62 µg/ml, EC90s 
between 4.91–6.51 µg/ml. At 3h post treatment, IC50s of the different strains were 
between 0.68–0.94 µg/ml, IC90s between 2.08–2.90 µg/ml. EC50s were between 
1.25–1.62 µg/ml, EC90s between 3.44–4.62 µg/ml. At 6h post treatment, IC50s of the 
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different strains were between 0.53–0.77 µg/ml, IC90s between 1.45–2.36 µg/ml. 
EC50s were between 0.91–1.28 µg/ml, EC90s between 2.36–3.62 µg/ml.  
 
ATCC 30001 (highly metronidazole-sensitive) was the least susceptible strain, ATCC 
50138 (metronidazole-resistant) the second-least susceptible, TV2 (metronidazole-
sensitive) the second-most susceptible, and ATCC 30236 (metronidazole-sensitive) 
was the most susceptible strain. However, the arithmetic means are close to each 
other within a range of 5% (29–34%) and show no correlation to their sensitivity to 
metronidazole (Tab. 9). Regarding EC50s and EC90s, TV2 and ATCC 50138 were 
rather similar to each other, and closer to ATCC 30001 than to ATCC 30236. 
Interestingly, ATCC 30001 had the highest values of EC, whereas TV2 had the 
highest IC90, and ATCC 50138 had the highest IC50. ATCC 30236 was the most 
susceptible strain in all cases.  
 
As the Levene-Test (Tab. 10) shows, the control “pentamycin 28% (20 µg/ml)” was 
highest significant with 0% at ICs and significant with 1.7% at ECs. The control 
“metronidazole (50 µg/ml) was significant with 3.3% at ICs but not significant with 
23.7% at ECs due to large deviations between the measurements. 
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3.4   Protein composition pre and post treatment 
 
3.4.1    Comparison of treated versus untreated cells 
 
Fig. 28 shows the result of 1D SDS-PAGE with ATCC 30001 (highly metronidazole-
sensitive), untreated and treated with 0.5 µg/ml pentamycin. The treated sample was 
lacking a protein band between 24 and 33 kDa (marked with dots).  
 
Fig. 29 shows the repeat of the experiment with 2D SDS- PAGE, however, a protein 
spot (circled) was stronger expressed here in the treated sample, which is contrary to 
the previous result.  
 
Fig. 30 shows the repeated experiment with both ATCC 30001 and TV2 
(metronidazole-sensitive), treated with 0.5 µg/ml. The result displayed in the first 
experiment (Fig. 21) could be reproduced with ATCC 30001, TV2 showed no 
significant differences.  
 
Fig. 31 and 32 show the reproduction of the previous experiment (Fig. 30), however, 
ATCC 30001 shows no significant differences here, and TV2 is differing in more and 
various spots, which is contrary to the first analysis too. 
 
As displayed in Fig. 33, there were no visible differences in strains treated with 1 
µg/ml at this time. However, it could be shown that higher doses like 2 µg/ml (Fig. 34) 
and 7 µg/ml (Fig. 35) led to weaker pronounced bandings in the treated samples.  
 
After treatment with 10 µg/ml, most of the protein bands were diminished sharply 
(Fig. 36). Proteins with more than 33 kDa seemed to be more affected and, in 
general, the diminished proteins seemed to be affected randomly and not specifically. 
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Fig. 28: 1D SDS-PAGE gel of ATCC 30001 untreated (-) and treated with 0.5 µg/ml  (+). 
 
  
Fig. 29: 1D SDS-PAGE gel of ATCC 30001, untreated (-, left) and treated with 0.5 µg/ml (+, right). 
Performed by David Leitsch. 
 
 
 
Fig. 30: ATCC 30001 and TV2, untreated (-) and treated with 0.5 µg/ml (+). 
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Fig. 31 & 32: ATCC 30001 (left) and TV2 (right), both treated with 0.5 µg/ml pentamycin. 
 
 
 
 
 
 
 
Fig. 33: ATCC 30001 and TV2 after treatment with 1 µg/ml pentamycin. 
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Fig. 34   Fig. 35 
Fig. 34: ATCC 50138 and 30236 after treatment with 2 µg/ml pentamycin, 
Fig. 35: ATCC 30001 after treatment with 7 µg/ml pentamycin. 
 
 
 
 
 
 
Fig. 36: ATCC 30236 after treatment with 10 µg/ml pentamycin. 
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Our hypothesis is that these patterns are based on a loss of cytoplasmatic material. A 
degradation of proteins by proteases or similar mechanisms seemed not to be 
plausible, considering the chemical properties of pentamycin and the short time of 
incubation. To prove our hypothesis, we performed a protein diminished assay to 
compare the protein amount of centrifuged cell extract and supernatant.  
 
 
3.4.2   Protein diminishment assay 
 
The comparison of untreated cells and cells treated with a highly toxic dose of 10 
µg/ml showed that the amount of proteins was increased in the supernatant and 
diminished in the cell extract with rising concentrations of pentamycin (fig. 37). The 
differences between cell extracts (marked with a dot) and the supernatants (marked 
with a frame) are strongly visible after application of 0 and 10 µg/ml pentamycin. The 
protein bands of samples treated with 10 µg/ml are distinctly diminished compared to 
the negative control. Obviously nearly all proteins have disappeared or were 
degraded. Samples treated with 2 and 5 µg/ml showed diminished protein bands with 
intermediate intensity. The lanes of the supernatant show the converse effect: The 
supernatant of cells treated with 10 µg/ml displays more and stronger protein bands 
than the negative control. According to this, an accretion of proteins in the 
extracellular environment can be stated. 
 
The presence of proteins in untreated cells is explainable as unavoidable 
entrainment of proteins when separating the supernatant from the cell pellets and the 
natural presence of lysed cells. 
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ATCC 30001                                                          TV2 
 
  
ATCC 30236                                                          ATCC 50138 
 
Fig. 37: From left to right: Protein marker “MW” (PeqLab), 0 µg/ml (cells), 0 µg/ml (supernatant), 2 
µg/ml (cells), 2 µg/ml (supernatant), 5 µg/ml (cells), 5 µg/ml (supernatant), 10 µg/ml (cells), 10 µg/ml 
(supernatant). Z = cells, Ü = supernatant.  
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3.5 Long-term treatment and adaption 
 
3.5.1 Morphology of trichomonads in long-term treatment 
 
During continuous long-term treatment over six months, partial adaption could be 
observed. The drug admission with sublethal concentrations until 1 µg/ml had no 
effect on the appearance of the cells, however, up from 1 µg/ml cellular discomfort, 
impairment of motility and changes of morphology (round forms) were observable. 
However, the round forms did not lyse finally as it happened after treatment with 
higher doses, moreover, they were still motile and rotary, and after a certain time of 
regeneration they regained their vitality. Remarkably, they also appeared with 
multiple nuclei (Fig. 38).  
 
After the appliance of higher sublethal concentrations (between 1 and 3 µg/ml), the 
cells were impaired in their motility and vitality from several hours to days, but they 
were also able to regenerate from the stress after stopping the treatment. Partly, the 
cells appeared also larger (Fig. 39).  
 
It was noticeable that pentamycin has a cumulative effect. The effect of adding 3 
µg/ml for one time a day or 1 µg/ml for three times a day was all about the same. TV2 
(metronidazole-sensitive) seemed to be more susceptible to the treatment than the 
other strains, however, this was only observed and not proved experimentally.  
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Fig. 38: A rounded trichomonad cell with multiple nuclei and rotary motions after treatment with 
sublethal doses of pentamycin (Photo: M. Syrowatka). 
 
 
 
  
Fig. 39: ATCC 30001; untreated and vital cells (left), cells after four months of resistance treatment 
(right).  
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3.5.2  Recordable adaption to pentamycin 
 
Fig. 40–42 and tab. 11–12 display the higher tolerance of strain ATCC 50138 
(metronidazole-resistant) to pentamycin after 4 and 5 months of continuous treatment 
with sublethal doses (see 2.11). After 4 months, the cells did not show any distinctive 
differences: After 1h of incubation, their susceptibility was even 9% higher than the 
susceptibility of the untreated cells. 3h after incubation the susceptibility was about 
12% lower, and after 6h it was about 33% lower. The values were far more distinctive 
after 5 months:  
 
At 1h of post treatment the susceptibility was 44% lower, after 3h about 70% and 
after 6h about 85% lower. A percentage of cells was still vital at 10 µg/ml, a dose that 
leads to EC100 in wildtypes. However, the susceptibility of the cells also increased 
with longer incubation time and finally led to 100% lysis  at 15 µg/ml after 3 and 6 
hours. All in all, after 4 months the susceptibility was reduced about 8.4% and after 5 
months about 63%. 
 
As shown in tab. 11 and 12, EC50s were higher – although not significantly – and 
have ascended after continuous treatment within 5 months. Thus, a lower 
susceptibility and adaption of trichomonads to pentamycin can be assumed.  
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Fig. 40: Vitality of ATCC 50138 and 50138R, 1h after treatment with pentamycin. 
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Fig. 41: Vitality of ATCC 50138 and 50138R, 3h after treatment with pentamycin. 
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Fig. 42: Vitality of ATCC 50138 and 50138R, 6h after treatment with pentamycin. 
 
 
 
 
Tab. 11: EC50 of ATCC 50138R after 4 and 5 months of treatment. 
ATCC 50138 R  1h 3h 6h 
EC50 (4 months) 2,20 1,84 1,76 
EC50 (5 months) 6,40 4,17 4,42 
 
 
Tab. 12: Comparative EC50  of ATCC 50138 (wildtype, see also tab. 6). 
ATCC 50138 1h 3h 6h 
EC50 2,62 1,51 1,06 
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3.5.3  Cross resistance to amphotericin B 
 
 
ATCC 30236 
 
Fig. 43–45 and tab. 13–14 display the relative vitality of ATCC 30236 (metronidazole-
sensitive), wildtype and R-strain, after 4 months of long-term treatment, both treated 
with various doses of amphotericin B. Remarkably, R-strains were about 23% more 
sensitive to amphotericin B in general, especially at higher doses – up from 200 
µg/ml after 1h, and up from 150 µg/ml after 3 and 6h. 
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Fig. 43: Vitality of ATCC 30236 and 30236R, after 1h of treatment with pentamycin. 
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Fig. 44: Vitality of ATCC 30236 and 30236R, after 3h of treatment with pentamycin. 
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Fig. 45: Vitality of ATCC 30236 and 30236R, after 6h of treatment with pentamycin. 
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Tab. 13: EC50 of ATCC 30236R after treatment with amphotericin B. 
30236R 1h 3h 6h 
EC 50 121,33 103,96 76,41 
 
Tab. 14: Comparative EC50 of ATCC 30236 after treatment with amphotericin B (see also Tab. 3). 
ATCC 30236 1h 3h 6h 
EC 50 201,10 176,17 127,29 
 
 
 
 
TV2 
 
Fig. 46–48 and tab. 15–16 display the relative vitality of TV2 (metronidazole-
sensitive), wildtype and R-strain after 4 months of long-term treatment, both treated 
with various concentrations of amphotericin B. R-strains were more susceptible, 
especially at higher doses. Up from 300 µg/ml, R-strains have reached EC100  within 
1h, whereas wildtypes were still viable at 400 µg/ml. In general, the sensitivity of R-
strains was about 25.8% higher than in wildtypes. 
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Fig. 46: Vitality of TV2 and TV2R, after 1h of treatment with pentamycin. 
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Fig. 47: Vitality of TV2 and TV2R, after 3h of treatment with pentamycin. 
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Fig. 48: Vitality of TV2 and TV2R, after 6h of treatment with pentamycin. 
 
 
 
Tab. 15: EC50 of TV2R after treatment with amphotericin B. 
TV2R 1h 3h 6h 
EC 50 56,71 75,67 70,22 
 
Tab. 16: Comparative EC50 of ATCC 30236 after treatment with amphotericin B (see also Tab. 2). 
TV2 1h 3h 6h 
EC 50 162,46 153,85 108,18 
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In both cases, EC50s of R-strains have decreased, comparing to wildtypes. ATCC 
30236R was 2 times more susceptible to amphotericin B than wildtype, whereas 
TV2R was more than 3 times more susceptible after 1h. After 3h, the span between 
wildtype and R-strain was not so large anymore but still about 1.5 to 2 times in 
difference. ATCC 30236R showed higher EC values than TV2R in general. R-strains 
were more susceptible to a consecutive treatment with amphotericin B than untreated 
strains and a synergistic effect of both drugs can be stated. 
 
 
3.5.4  Protein profile of wildtype and adapted strains 
 
Fig. 49 shows a 1D SDS-PAGE gel, performed with both ATCC 30001 (highly 
metronidazole-sensitive) and ATCC 30236 (metronidazole-sensitive) to compare 
wildtype, single-time treated and long-term treated trichomonads. Whereas ATCC 
30001 showed no significant alterations in its protein profile, ATCC 30236 showed 
remarkable differences. Lane 5, treated once with 10 µg/ml, displays the dramatic 
effect of high doses in comparison to its analogue, lane 2, which has been treated 
once with 1 µg/ml.  
 
Long-term treated cells – in treatment for two months and at a dose level of 1 µg/ml 
at that time – showed a more variegated protein profile than single-time treated 
trichomonads, as displayed in lane 6: The upper, heavy-weighted proteins of a 
molecular mass between 250 kDa and 36 kDa seemed to be stronger diminished in 
treated cells whereas the light-weighted proteins between 36 kDa and 10 kDa were 
stronger expressed than those of untreated cells.  
 
 
 
RESULTS 
 
108
           M                         1          2          3                          4            5            6 
 
Fig. 49: M: Marker; 1: ATCC 30001, untreated; 2: ATCC 30001, treated once with 1 µg/ml pentamycin;  
3: ATCC 30001 in resistance treatment after 2 months, last applied dose 1 µg/ml; 4: ATCC 30236, 
untreated; 5: ATCC 30236, treated once with 10 µg/ml pentamycin; 6: ATCC 30236, in resistance 
treatment after two months, last applied dose 1 µg/ml. 
 
 
Fig. 50–54 show partly noticeable variations in the protein profile of wildtypes and R-
strains. For example, fig. 53 shows a gel containing spot 4 which was not expressed 
on the other gels in that way. In the wildytpe it was poorly expressed, whereas in the 
R-strain it was distinctly stronger expressed – a pattern that was not detectable in the 
other analyses where it was expressed weakly or was completely absent in wildtypes 
and R-strains. In fact, fig. 53 completely discerns from the other gels by its 
expression profile that is nearly completely diminished except spot 4.  
 
The respective proteins were marked and numbered. Actin (1), lactate 
dehydrogenase (LDH) (2), enolase (3), unidentified protein spots (4), unidentified 
protein spot (5), pyruvate ferredoxin oxido-reductase (PFOR) (6), hydrogenosomal 
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malate dehydrogenase (hMDH) (7), cytosolic malate dehydrogenase (cMDH) (8), 
alcohol dehydrogenase 1 (ADH1) (9), and further unidentified protein spots (10, 11, 
12, 13).  
 
Spots 1, 3, 7, 8, 9, 10, 11, 12, 13 were distinctly differing from their analogues in 
untreated cells, showing a visible fragmentation and degradation in R-strains, most 
probably due to long-term treatment. In 50% of cases, LDH was significantly stronger 
expressed in R-strains than in wildtypes (Fig. 50–52). PFOR was generally strongly 
diminished (Fig. 50–53). This key enzyme in the hydrogenosomal metabolism should 
normally be more intense. Indeed, in fig. 54 and 55 it was expressed more distinctive, 
due to the addition of iron (see 2.2).  
 
Spot 5, an unidentified protein, was only visible in fig. 51 and may probably be a 
fragmentation product of actin. Spot X was only detectable in fig. 50 (wildtype only) 
and also in fig. 55 in all strains. It failed to appear mostly, probably due to technical 
problems that occurred during performing the analysis.  
 
cMDH also showed fragmentation, however, in several variations. In fig. 50 and 51, a 
shifted spot of a heavier protein fragment appeared additionally, whereat fig. 52 
shows dissociation into proteins of equal molecular weight. In fig. 54, an additional 
spot of a dissociated, light-weighted protein fragment appeared under the original 
spot.  
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Fig. 50: ATCC 30001 – (left) and R (right), after 10 weeks of treatment (21.1.2010).  
  
Fig. 51: ATCC 30001 – (left) and R (right), after 10 weeks of treatment (29.1.2010). 
  
Fig. 52: ATCC 30236 – (left) and R (right), after 3 months of treatment (4.2.2010). 
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Fig. 53: ATCC 30001 – (left) and R (right), after 14 weeks of treatment (18.2.2010). 
  
Fig. 54: ATCC 50138- (left) and R (right), after 6 months of treatment (26.3.2010). 
 
The manual identification of these proteins refers to LEITSCH et al. (2009). 
 
The final experiment (Fig. 55) was performed to exclude the possibility of protein 
fragmentation and proteolysis as an error source for variegated protein profiles (see 
2.9). It shows that the fragmentation of proteins was not reproducible, even not by 
avoiding a previous treatment with pentamycin. Also the expected proof for an 
overexpression of LDH in treated trichomonads failed. Moreover, it is stronger 
expressed in the wildtype, both untreated and treated, and absent in the R-strains, 
RESULTS 
 
112
both untreated and treated too. To prove its hereby role in indicating cell damage and 
proteolysis, a consecutive measurement of LDH activity was performed.   
 
  
  
Fig. 55: ATCC 30001 wildtype, not treated (up left), treated with 2.5 µg/ml (up right), ATCC 30001 R-
strain, not treated (bottom left), treated with 2.5 µg/ml (bottom right).  Performed by David Leitsch. 
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3.5.5  Lactate dehydrogenase enzyme activity assay 
 
Tab. 17 shows the results of the measurements of the LDH-induced NADH oxidation 
absorption rate of wildtypes and R-strains. In all cases, the values were very close to 
each other and even almost identical, so that a significant difference of the LDH 
expression grade in wildtypes and R-strains could be excluded.  
 
 
 Tab. 17: Measurements of the NADH oxidation absorption rate of ATCC 30001 wildtype and R-strain. 
with substrate (pyruvate)  without substrate (blank) 
ATCC 30001 ATCC 30001 R  ATCC 30001 ATCC 30001 R 
-0,0135 -0,0076  -0,008 -0,0025 
-0,1165 -0,1257  -0,1004 -0,0509 
-0,213 -0,247  -0,2006 -0,1254 
-0,3226 -0,33  -0,311 -0,2057 
 
 
 
3.6 Cell permeability assay 
 
The following tables 18–24 display three different approaches in which the pH was 
measured, before and after addition of pentamycin and in certain time intervals. The 
values in bold show the lowest acidic pH which was at low, sublethal doses in all 
cases: mostly at 0.5 µg/ml, twice at 0.25 µg/ml and once at 1 µg/ml. The first 
experiment was a blank test and it was measured for one time after 30 minutes. 
Here, the most significant pH difference was at 0.5 µg/ml. In the next experiment, the 
result was also 0.5 µg/ml at 1, 3, and 6 h post treatment. In the final experiment, the 
most significant pH difference after 1 and 3 h was at 0.25 µg/ml and after 6h at both 
0.25 and 1 µg/ml (bold).  
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Tab. 18: pH changes 30 min after drug administration (strain TV2). 
Pent. (µg/ml) pH change 
0 -0,002 
0,5 -0,06 
1 0 
2 -0,005 
3 0,02 
4 0 
5 -0,01 
10 -0,001 
 
 
Tab. 19: pH changes, 60 min after drug administration (strain TV2). 
Pent. (µg/ml) pH change 
0 0 
0,25 -0,002 
0,5 -0,04 
1 -0,015 
2 -0,025 
3 -0,025 
5 -0,02 
10 -0,025 
 
 
Tab. 20: pH changes, 3 h after drug administration (strain TV2). 
Pent. (µg/ml) pH change 
0 -0,005 
0,25 0 
0,5 -0,04 
1 -0,02 
2 -0,02 
3 0 
5 -0,01 
10 0 
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Tab. 21: pH changes, 6 h after drug administration (strain TV2). 
Pent. (µg/ml) pH change 
0 -0,005 
0,25 -0,01 
0,5 -0,04 
1 -0,03 
2 -0,025 
3 0,005 
5 0,005 
10 0,005 
 
 
Tab. 22: pH changes, 60 min after drug administration (strain ATCC 30236). 
Pent. (µg/ml) pH change 
0 -0,002 
0,25 -0,001 
0,5 -0,002 
1 0 
2 0,011 
3 0,004 
5 0,01 
10 0,05 
 
Tab. 23: pH changes, 3 h after drug administration (strain ATCC 30236): 
Pent. (µg/ml) pH change 
0 0,001 
0,25 -0,002 
0,5 -0,001 
1 0,011 
2 0,019 
3 0,055 
5 0,05 
10 0,095 
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Tab. 24: pH changes, 6 h after drug administration (strain ATCC 30236): 
Pent. (µg/ml) pH change 
0 0,001 
0,25 0 
0,5 0,005 
1 0 
2 0,022 
3 0,035 
5 0,038 
10 0,09 
 
 
 
3.7 Nile Red stain 
 
The purpose of this experimental procedure was to observe altered membrane 
properties in pentamycin-treated trichomonads. The lipophilic character of Nile Red 
leads to a shift of emission from red to yellow according to the degree of 
hydrophobicity of lipids. Polar lipids like phospholipids appear red whereas neutral 
lipids like cholesterol appaer yellow (DIAZ et al., 2008). 
 
In this study, the analysis however did not produced useful results. Untreated and 
treated cells were stained to monitor a difference in the membrane composition. After 
the stain, cells appeared as orange with yellow dots but alterations of the cell shape 
and colour were not visible. However, due to the viscosity of glycerol, they appeared 
as blurry and were difficult to handle. Photographs were taken but the results were 
not successful as all photos were black after developing. 
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4   Discussion 
 
4.1 Mode of action of pentamycin 
 
4.1.1  Phenotype of pentamycin-treated trichomonads 
 
Motile, flagellated and pear-shaped trichomonads were observable in axenic cell 
culture under normal conditions (37°C). When attached to their host cells – or, in this 
case (in vitro), to the bottom of the culture flask – trichomonads alter their 
morphology to an amoeboid, amorphous shape (ARROYO et al., 1993). Additionally, 
they can also appear as round cells with or without flagella as well as with two and 
more nuclei (ABONYI, 1995).  
 
We observed round, non-flagellated, enlarged, and comparably immotile 
trichomonads when they were exposed to effective concentrations of pentamycin or 
when they were stressed in general (cellular discomfort due to low temperature, high 
cell densities, low nutrient supply, old medium). However, high doses of 5 µg/ml (and 
above) pentamycin led to a fast disruption and lysis of the cell before the parasites 
could become rounded. ABONYI (1995) described these forms as “developmental 
stages preceding the appearance of mononuclear flagellate cells”, however, cell 
divisions were described as amitotic and without the characteristics of mitosis. 
Although the biology of these round forms is still unknown, it seems that stress may 
be the connection between our and ABONYI’S (1995) observation.  
 
In 2008, MALIK et al. reported on the presence of homolog genes responsible for 
genetic recombination and meiosis in T. vaginalis. Amongst others, the authors 
discovered that 7 of 29 meiotic genes were expressed under stress (low-iron 
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conditions, cold), whereas three of them were expressed exclusively under these 
stress conditions. Moreover, one of these three genes (Msh5) is described to be 
meiosis-specific, directing Holliday junctions to a crossover (MALIK et al., 2008).  
 
Comparing these findings with that of ABONYI (1995) and MALIK et al. (2008), stress 
seems to be the trigger for round forms and genetic recombination. It is thinkable that 
the developmental stages with mutliple nuclei, which ABONYI (1995) described and 
which we could observe after drug administration, represent a stress-induced stage 
in which genetic recombination occurs, maybe as a response and reaction of the 
cells to stress. Further investigations of this phenomenon could be important in 
understanding the biology of T. vaginalis and other parasitic protozoa.  
 
 
4.1.2   Protein profiles of pentamycin-treated trichomonads 
 
Trichomonads treated with pentamycin showed an altered protein profile. Protein 
bands were diminished in their intensity or completely absent. The effect was more 
distinct, the higher the applied drug dose was. At low, sublethal doses there was 
either no visible effect, or only one or more single proteins were affected. After 
treatment with higher doses (> 5 µg/ml), most of the proteins seemed to be degraded 
or absconded. Interestingly, the patterns of the affected proteins were not identical 
after repeating the experiments under the same conditions. Therefore, the drug does 
not seem to act specifically, but rather randomly. Hence, a direct interaction of 
pentamycin and the investigated proteins of the cell seems implausible. Also, 
epigenetic mechanisms like down-regulation of proteins or expression of proteinases 
are rather unlikely as a source because it would take more time of incubation until 
measurable results would be detectable. 
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The protein diminishment assay at which drug administration resulted in an accretion 
of proteins in the supernatant and in a decrease of proteins in the cell extract –
especially at high doses – provided evidence that proteins leak out of the cell rather 
than being degraded. Thus, it can be said that the source are cytotoxic effects that 
lead to cell lysis.  
 
These observations and conclusions fit to previous studies on the mode of action of 
pentamycin, and polyenes in general. In studies in the 1960s, it was reported that 
polyenes such as nystatin and amphotericin B cause membrane distortion in yeast or 
Candidia cells and, consequently, a leak out of cytoplasmic material, which was 
considered as the primary reason for cell death (SUTTON et al., 1961; DEMEL & VAN 
DEENEN, 1965; ZYGMUNT, 1966). In the 1970s, these investigations on the mechanism 
of action of polyenes were continued. DE KRUIJFF et al. (1974) described the effect of 
several polyenes such as amphotericin B, nystatin and etruscomycin on 
Acholeplasma laidlawii cells as a formation of transmembrane pores with subsequent 
membrane disruption (DE KRUIJFF et al., 1974).  
 
In 1978, it could be shown that an altered membrane permeability depends on the 
applied drug dose: At high doses, polyenes led to a complete disruption of yeast 
cells, whereas at low doses the cells were primarily not disrupted but lost potassium 
and other small ions as a consequence of membrane pore formation (PALACIOS & 
SERRANO, 1978). This also fits to the current study as we observed 100% of lysed 
cells at high doses (10 µg/ml and above) after a short time of incubation, whereas at 
lower doses (below 5 µg/ml) the cells were impaired, but not lysed. PALACIOS & 
SERRANO (1978) also measured a lower pH value in the cell environment after 
appliance of low and sublethal drug doses due to the exclusive outstream of small 
ions including H+. The cell permeability assay in our study also revealed the lowest 
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pH values at 0.25 µg/ml and 0.5 µg/ml, respectively, after treatment with pentamycin 
in a range from 0.25 µg/ml to 10 µg/ml. 
 
In general, the effect seems to depend on the molecular weight of the respective 
polyene and the applied dose. Polyene-induced membrane pores with loss of 
intracellular ions but no loss of viability have also been reported as well as formation 
of large planar aggregates between molecules of the membrane and the polyene 
leading to membrane instability (KERRIDGE, 1979; CASTANHO et al., 1992). For 
pentamycin in particular, it has been reported that it may enhance the effect of the 
cancer chemotherapeutic agent bleomycin by increasing the permeability of tumour 
cells for bleomycin which acts as an inhibitor of DNA, RNA, and protein synthesis 
(NAKASHIMA et al., 1974; TWENTYMAN, 1976). 
 
These observations stand for a mode of action based on loss of membrane stability 
and resulting in leak out of cytoplasmic cell compartments, as demonstrated in this 
study.  
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4.1.3   Mode of action of pentamycin at molecular level and  compared 
to metronidazole 
 
It has been assumed that the mode of action of pentamycin is comparable to that of 
other polyenes and is based on an interaction with the eukaryotic cell membrane. 
However, the molecular mode of action and the induction of cell death have still not 
been entirely elucidated. Several studies from the 1960s to the 1980s have been 
published on this question that should be reviewed here shortly: 
 
Polyenes, a subclass of the chemical class of the macrolides, have – in addition to 
the lactonized macrocyclic ring of carbon atoms – a series of two to seven 
conjugated double bonds. All organisms that are susceptible to polyenes contain 
sterols in their cell membrane and are eukaryotic; bacteria are unaffected by 
polyenes as they do not contain sterols and have a cell wall, in addition to their cell 
membrane (HAMILTON-MILLER, 1973). However, BOLARD (1986) has stated that sterols 
are not a primal requirement for polyene susceptibility. Apart from that, he could 
show that the addition of cholesterol to filipin causes a spectral change indicating a 
direct binding between these two molecules. Further, when sterols are in aequous 
solution, the presence of a cholestane ring and a ∆22 double bond is required for 
optimal interaction.  
 
However, in the liposomal system – when the sterol is embedded in a natural or 
artificial membrane – an additional 3β-OH bond on the sterol nucleus is required for 
optimal interaction (NORMAN et al., 1972). Evidence for a binding of polyenes to 
sterols has also been given by the addition of free sterols into the culture medium 
which prevented the drug from binding with the sterols of the membrane (GHANNOUM 
& RICE, 1999). Further criteria for a binding are the distribution of double bonds in the 
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nucleus of the sterol that are related to differing polyene susceptibilities and the 
molecular weight of the polyene: polyenes with lower molecular weight are more toxic 
than those with higher molecular weight. This would mean, in particular, that 
pentamycin as a pentaene is more toxic than amphotericin B (a heptaene) but less 
toxic than dienes, trienes, and tetraenes (nystatin) (HSUCHEN & FEINGOLD, 1973; 
HOLZ, 1974; KERRIDGE, 1979).  
 
Since it is known that the target of polyenes are sterols of the cell membrane, the 
mechanism of action has been proposed as following: in case of amphotericin B 
(heptaene) and nystatin (tetraene), hydrogen bonds are formed between their OH-
group and that of the sterol. As this bond is linked together by van der Waals-forces, 
the hydroxyl side of the polyene faces inward which leads – together with a second 
polyene that is linked to the adjacent sterol – to formation of pores with a defined 
annulus. This configuration leads to damage of the cell membrane, an altered 
permeability with leakage of cytoplasmic material like proteins, and finally to cell 
death (KERRIDGE, 1979; GHANNOUM & RICE, 1999).  
 
Apart from that, several authors (HAMMOND et al., 1974; HAMMOND & KLIGER, 1974; 
GALE, 1974; CHEN et al., 1978; JOHNSON et al., 1978) have stated that a dissociation 
of K+ permeability and leakage is a hallmark of the polyene interaction with the 
membrane, however, this action may not be primarily responsible for necrosis. Also, 
CHEN et al. (1978) have suggested that the induced aequous pores may not be the 
primary reason for the death of the cell; the authors found vital cells with loss of 
cytoplasmic material but no loss of viability.  
 
PALACIOS & SERRANO (1978) have demonstrated an alternative action mechanism 
basing on amphotericin B-induced inhibition of maltose fermentation of 
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Saccharomyces cerevisiae and an increase of proton permeability of the cell 
membrane. This would also fit to the observation of K+ leakage which is linked to the 
proton gradient (KERRIDGE, 1979).  
 
BOLARD (1986) has differentiated the action mechanism of polyenes into that of large 
polyenes which lead to alteration of membrane fluidity and permeability and that of 
short polyenes which lead to membrane disruption. Moreover, he proposed an 
additional influence of environmental factors: the ratio of antibiotics and sterols, the 
mode of addition of antibiotics, the incubation time and notably the gel state of the 
membrane, which is not identical in cells, making it sensitive for polyenes even if they 
do not contain sterols. Also the peroxidation of membrane lipids and inhibition of 
membrane-bound enzymes have been observed and assigned to the toxic effect of 
polyenes (BOLARD, 1986). 
 
A recent study on germinating conidia of Penicillium discolor could show that 
natamycin (pentaene) works differently than nystatin (tetraene) and filipin (pentaene), 
which both act by disrupting the plasma membrane while natamycin binds to 
ergosterol but inhibits endocytosis and further fungal growth (VAN LEEUWEN et al., 
2009). 
 
In the context of polyenes against erythrocytes infected with Plasmodium falciparum, 
amphotericin B has been reported to be affine for oxidized cholesterol. This may 
derive from the oxidation of the erythrocyte membrane caused by the infection with 
the malaria parasite (WIEHART et al., 2006). 
 
Summing up these studies, the described cytolytic mode of action is corroborated by 
the results of the current study. Although the members of the polyenes also have 
characteristic properties, the general mode of action is the same for all of them, thus, 
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studies on amphotericin B, nystatin and filipin can provide a basis for investigations 
on pentamycin. Also the binding properties to ergosterol and cholesterol are 
comparable.  
 
Thus, it can be stated that the antibiotic effect of pentamycin against fungal and 
protozoan cells relies on a membranolytic, osmotic mode of action as a consequence 
of an interaction with polyene and ergosterol (in fungi, Trypanosoma and Leishmania) 
or cholesterol in most other protozoa. Our observation of a more rapid cell lysis after 
treatment with higher doses fits also with BOLARD (1986) who described “larger pores, 
holes, or other sources of membrane damage” after “treatment with high doses” 
(BOLARD, 1986).  
 
This mode of action of pentamycin, which also has a dramatic visible effect, is 
different to that of metronidazole, which is also an explanation for the non-selectivity 
of metronidazole-susceptible and -resistant strains of T. vaginalis to pentamycin. The 
mode of action of metronidazole can be summarized as following: 
 
Metronidazole diffuses into the cell where it is reduced into its active form and leads 
to the release of free radicals which induce DNA damage and cell death within a few 
hours (FREEMAN et al., 1997). This mechanism takes action inside the cell and is also 
the reason for a different appearance of metronidazole-treated cells: They are 
observable as immotile and can be distinguished from vital cells by trypan blue stain, 
whereas pentamycin-treated trichomonads are visibly disrupted and lysed.  
 
Indeed, this basic mechanism is generally accepted but there are diverse theories on 
the molecular mode of action of metronidazole. MÜLLER (1986) proposed an 
anaerobic reduction of the NO2-group of metronidazole by PFOR by concomitant 
oxidation of pyruvate to acetyl-CoA. Consequently, cytotoxic nitroradicals lead to 
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DNA strand breaks, inhibition of mitosis, and finally to cell death. HRDY et al. (2005) 
postulated an alternative mechanism whereby the electron source is malate instead 
of pyruvate and the reducing enzyme is NAD:ferredoxin oxidoreductase instead of 
PFOR, however, the general pathway does not differ from that proposed by MÜLLER 
(1986).  
 
In 2009, LEITSCH et al. suggested a novel and completely different mode of action of 
metronidazole. The authors discovered that the antioxidative enzyme thioredoxin 
reductase reduces metronidazole which subsequently forms covalent adducts with 
thioredoxin reductase and further proteins that are involved in the thioredoxin-
mediated redox regulation. Hence, the activity of these enzymes is sharply 
descreased. Since thioredoxin is essential for decomposition of damaging peroxides, 
the toxic effect of metronidazole seems to be based rather on the obviation of 
efficient cell detoxication (LEITSCH et al., 2009).  
 
Although these points of metronidazole action remain still unclear, it is generally 
accepted that it harms the cell via release of radicals and oxidative stress by its 
metabolization. In this case, a benefit for pentamycin as an anti-trichomonal 
pharmaceutical drug may be its faster and more visible effect, whereas its 
disadvantage may be its non-selectivity to target cells which would require a local, 
topical application form.  
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4.2 Dose-response relationship 
 
4.2.1  Microscopic observations 
 
As mentioned before, a positive correlation of dosage regimen, incubation time, and 
impaired and lysed cells can be stated. At lower doses from 0.5–4 µg/ml, more 
inhibited cells – that were partially rounded and resembled to blebs – than lysed cells 
were observable. With increasing dose, the amount of lysed cells was increasing too 
whereas the amount of rounded, inhibited cells was diminishing. It is obvious that a 
higher dose led to faster cell death; therefore, the incubation time might be too short 
for rounding and blebbing. As nearly all cells treated with 10 µg/ml and above were 
lysed, it seems plausible that the amount of pentamycin molecules that are able to 
bind to membrane cholesterol correlates with the severity of cell damage as more 
locations with pores may lead to faster necrosis.  
 
We also observed granula-like particles around the cells after a dose of 50 µg/ml – 
which is more than a ternary lethal overdose. These particles only appeared at this 
dose. Their origin is unclear, however, redundant pentamycin molecules – which 
might be thinkable after such an high dose as there would be more molecules of 
pentamycin than free sterols – may not bind to membrane cholesterol, but form 
aggregations with lipids from the leaked cytoplasms or from ingredients of the 
medium.  
 
The morphology of pentamycin-treated trichomonads resembles to that of 
miltefosine-treated trichomonads which also resulted in “rounding up, blebbing, and 
total lysis of the organism” (BLAHA et al., 2006). Miltefosine, an anitleishmanial 
antibiotic, belongs to the alkylphosphocholines but has a similar mode of action to 
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pentamycin as it also interacts with the cell membrane. Also, low doses require 
longer incubation time whereas high doses induce necrosis within in a short time and 
“without prior rounding up”, like in this current study (BLAHA et al., 2006).  
 
The blebbing and rounding of the cells might also have another possible background. 
According to ABONYI (1995), BLAHA et al. (2006) and MALIK et al. (2008), these stages 
are physiological reactions to stress such as drug administration and nutrient 
depletion. A further explanation may be that the round forms are connected with 
apoptosis. It was postulated that drug treatment leads to programmed cell death with 
its characteristic features (such as nuclear condensation and reduced cytoplasm) in 
protozoans, like metronidazole in Blastocystis hominis (NASIRUDEEN et al., 2001, 
2004). Recently, apoptosis – which was formerly believed to be a feature of 
multicellular organisms – was also proved in T. vaginalis cells exposed to stress 
conditions as well as formation of round pseudocysts with internalized flagella 
(BENCHIMOL, 2008). The protozoan parasites seem to react to toxic substances in the 
enivronment and induce apoptosis as a defense strategy for the welfare of the whole 
cell population. A smaller cell density increases the probability to evade the hosts’ 
immune system (NASIRUDEEN et al., 2004). Especially when protozoans are 
assembled in dense batches, this might be a plausible action and resembles also to 
the purpose of apoptosis in multicellular organisms: to protect the population of cells 
with programmed cell suicide. It seems that the parasites response to the presence 
of cytokines and antibiotic drugs with the same physiological reaction; but in contrary 
to the immune system, antibiotic drugs are not deceivable in that way. 
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4.2.2  Efficacy of pentamycin 
 
The impact of pure pentamycin is strong and fast, requiring only a small dose of 15 
µg/ml to eradicate 100% of trichomonads within 1h. It is a formidable effectivity 
compared to that of pentamycin with less purity (28%) and metronidazole. There are 
other antibiotic drugs that have a similar efficacy but also more disadvantages. 
 
N-chlorotaurine, an oxidant produced by human immune cells to combat infections 
and inflammations which has also been in test use against T. vaginalis, also showed 
lower effectory concentrations than metronidazole, however, it does not reach the 
efficacy of pentamycin  (EC50 after 1h: 1.636 mg/ml for the highly metronidazole-
sensitive strain ATCC 30001, and 5.08 mg/ml for the metronidazole-resistant strain 
ATCC 50138, respectively). Moreover, N-chlorotaurine is not applicable as an 
antitrichomonal drug due to its low stability (FÜRNKRANZ et al., 2010).  
 
Also Hamycin, a polyene similar to amphotericin B, showed a similar trichomonicidal 
activity of 1 µg/ml but also killed mammalian tissue cell culture lines HeLa and BHK-
21 at this concentration, which makes it inapplicable against trichomoniasis too 
(LUSHBAUGH et al., 1995). The efficacy of pentamycin against T. vaginalis is most 
likely comparable to miltefosine which showed similar values (EC50 of 3.26 µg/ml 
after 30 min) (BLAHA et al., 2006) but also shows partially severe side effects. 
 
The remarkable low inhibitory and effectory concentrations of pentamycin (94%) 
compared to pentamycin (28%) and metronidazole may be explainable by the higher 
purification grade of pentamycin (94%) on the one hand, and by its direct and 
expeditious mode of action on the other hand. The low dose that is required for an 
effective eradication of trichomonads may be advantageous for a topical application. 
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Because of its affinity for membrane sterols, it would also affect human cells, thus, it 
seems important to avoid side effects by a narrow sphere of action.  
 
A study on the safety, tolerability and pharmacokinetics of intravaginal pentamycin 
reported of “mild or moderate vaginal discharge and mild symptoms of vaginal 
irritation (mainly pruritus or vaginal sensation)” (FREY TIRRI et al., 2010) after the 
application of the drug. The patients received doses from 3 to 100 mg for a duration 
of 6 days (FREY TIRRI et al., 2010). In this case, a drug dose that can be adjusted to 
the number of trichomonads could help to avoid side effects. Also a re-formulation 
could alleviate adverse events. Amphotericin B, for instance, is far less toxic for the 
patient when applicated as a liposomal formulation (GHANNOUM & RICE, 1999).  
 
There was no significant difference between the four investigated strains in their 
sensitivites to pentamycin. All differently metronidazole-susceptible strains had nearly 
the same susceptibility to pentamycin as investigated by the dose-effect relationship 
tests. Thus, the sensitivity of trichomonads to metronidazole does not correlate with 
that to pentamycin. This is due to the different modes of action these drugs have and 
is a high advantage of pentamycin, as it can be used in patients infected with 
metronidazole-resistant strains. Hence, resistant trichomonads would be eliminated 
in the same way as metronidazole-sensitive strains. 
 
These findings are comparable to the in vitro activity of miltefosine against T. 
vaginalis where also four differently metronidazole-susceptible strains did not differ in 
their sensitivity to miltefosine (BLAHA et al., 2006).  
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4.3 Resistance 
 
4.3.1  Phenotype of adapted trichomonads 
 
Trichomonads, treated continuously with sublethal concentrations of pentamycin over 
a period of six months, appeared partly larger, impaired, and slower in their motility 
and their growth rate. These findings correlate with the observations in the reviews of 
HAMILTON-MILLER (1973) and GHANNOUM & RICE (1999), who reported of polyene-
resistant Candida strains that grow slower than the parental strains, have a greater 
cell size, and are less virulent. There is also remarked that polyploidy correlates 
directly with resistance to nystatin and cell size (HAMILTON-MILLER, 1973).  
 
A slower growth was also observed in metronidazole-resistant trichomonads (LEITSCH 
et al., 2010). These phenotypic appearances also correlate with the observations of 
ABONYI (1995) who described the round forms and assumed a developmental stage. 
It is likely that stress, in this case the treatment with pentamycin, is the source for 
rounding and polyploidy as it occurs in this stage, and also for genetic recombination 
that has been reported from T. vaginalis previously by MALIK et al. (2008). The 
authors discovered that the parasite expresses a set of 18 meiotic genes of which 7 
were expressed exclusively under stress – 5 under low iron conditions and 2 in cold-
induced pseudocysts. This set comprises genes involved in chromosome assembly 
and segregation, direction of Holliday junction to crossover, sister chromatid 
cohesion, DNA repair and more (MALIK et al., 2008). The pseudocysts induced by low 
temperature seem to be identical with the hereby observed round forms, not least 
because at lower temperatures (26°C, 20°C) we also found more rounded 
trichomonads.  
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It is thinkable that the round trichomonads are the link between induced stress and 
observed genetic recombination, which is in fact the same principle as in sexual 
reproduction: exchange of genetic material to enhance the fitness of the next 
generation. Although trichomonads are haploid and asexual organisms, a one-step 
meiosis that is confined to homologous recombination may be possible, as it was 
observed in Giardia intestinalis too (POXLEITNER et al., 2008).  
 
 
 
4.3.2   Establishment of an adaption to pentamycin and cross resistance to  
amphotericin B  
 
It is known that trichomonads can develop true resistance against metronidazole in 
vitro and in vivo whereas the effective mechanism of resistance is still controversial 
(KULDA, 1999; LEITSCH et al., 2010). In the current study, we wanted to monitor the 
process of long-term treatment with pentamycin and if trichomonads have the 
potential to develop resistance to pentamycin within six months. It could be shown 
that true resistance does not seem to occur. Cells continuously treated with higher 
doses – increasing by 0.5 µg/ml every other day – rather died than developed 
resistance, at the latest at 6 µg/ml. However, after stopping the treatment a partial 
recovery was observable after 24 hours. This may have its reason in cells that were 
not affected by the drug as they were inside in a cell cluster and could proliferate; a 
phenomenon called pseudo-resistance or passive resistance.  
 
The procedure of applying sublethal concentrations 2–3 times a day – starting at 0.25 
µg/ml and increasing cautiously the dose by about 0.1 µg/ml, depending on the 
health of trichomonads – led to an adaption to pentamycin. After 4 months, the 
sensitivity to pentamycin was found to be reduced about 8.5% and after 5 months 
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even about 63%. This proves an adaption of trichomonads to the drug, at least until 
doses of 15 µg/ml and more that still led to 100% lysis. These follow-up assays were 
performed two times with the metronidazole-resistant strain (ATCC 50138).  
 
True resistance – that also means a hereditary transmission – did not develop within 
six months which resembles previous investigations in polyene resistance. In the 
1970s, it was reported that even after 15 years of polyene antibiotic use against 
Candida, resistance never was a serious problem and only a few strains showed the 
ability to express resistance (HAMILTON-MILLER, 1973). In 1999, almost 30 years later, 
resistance – which was mainly investigated against amphotericin B and nystatin – 
was still rare and confined to less common species of Candida (GHANNOUM & RICE, 
1999). Recently, it could be shown that only one isolate of several Candida species 
expressed resistance against amphotericin B (AMRAN et al., 2011). Due to similarities 
between pentamycin and amphotericin B in chemical structure and mode of action, 
these properties could be allocated to pentamycin too.  
 
Although it is noted that “only a slight increase in resistance to polyenes would render 
them virtually useless as chemotherapeutic agents” (HAMILTON-MILLER, 1973), it is 
unclear whether the hereby observed increase of adaption would give a cause for 
concern. In the current study, doses of 15 µg/ml and above, always led to a complete 
eradication of trichomonads in vitro, even in adapted strains. Up from 5 µg/ml, no 
adaption was observable. Moreover, adaption was immediately lost when 
subcultured in fresh medium without the drug. 
 
Also, no cross resistance between the two polyenes pentamycin and amphotericin B 
was found in this study. On the contrary, after four months of continual, daily 
treatment with sublethal doses of pentamycin, strains expressed a higher sensitivity 
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to amphotericin B, namely about a fourth. Actually, the sensitivity of both strains 
resembled each other as ATCC 50138 (metronidazole-resistant) had an increased 
susceptibility about 23.2% and TV2 (metronidazole-sensitive) about 25.8%.  
 
Altogether, cross resistance can not only be excluded but a combination of both 
drugs would act in concordance which is simply explainable by the action mechanism 
of both polyenes and the increased accumulation of cholesterol-interacting 
molecules. Also because there are no reports of amphotericin B-resistant 
trichomonads until now, these findings look advantageous for a clinical use of 
pentamycin.  
 
 
4.3.3  Protein profile of long-term treated trichomonads 
 
Long-term treatment with pentamycin altered the protein profile of trichomonads but 
differently than single-dose treatment. Whereas single-dose treatment resulted in a 
diminishment and leak out of proteins, the consequence of long-term treatment 
seemed to be proteolysis as most of the altered protein spots disappeared or were 
shifted. We could exclude a change in the protein profile that might be an evidence 
for a physiological reaction of the cell and therefore resistance. Moreover, the 
patterns of the protein profiles were differing from each other, indicating an unspecific 
mode of action. 
 
It can be assumed that pentamycin and stress caused by long-term treatment, 
respectively, affect and impair proteins and lead to fragmentation. Thus, the spots 
were either missing (complete proteolysis) or partitioned and shifted in their position 
(fragmentation of a protein into smaller and light-weighted parts). For instance, actin, 
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a protein of the cytoskeleton, partly seemed to dissociate, as in treated cells more 
spots of actin and also a novel, unidentified actin spot (spot 5), were visible.  
 
Furthermore, some spots in treated trichomonads were more intense, which might be 
interpretable via stronger protein expression or adduct formation of protein 
fragments. As shown previously, covalent adducts are identifiable as novel protein 
spots and shifts of the respective proteins (LEITSCH et al., 2009; LEITSCH et al., 2010). 
However, the patterns of the spots in these experiments can be interpreted generally 
as a result of cellular discomfort caused by stress induced by drug administration.  
 
Indeed, LDH was most frequent altered protein and was continuously present in 50% 
of the gels. It was stronger expressed in treated cells but it was not possible to assign 
this to an increased protein expression or adduct formation. In clinical diagnosis, LDH 
is a parameter for damage of tissue and organs due to lysed cells and migration of 
cytoplasmic content into blood, plasma and serum. However, LDH can also be a 
reaction of the cell to insufficient energy production: LDH steps in when glycolysis 
expires as it produces lactic acid and NAD+ of pyruvate and NADH. NAD+ can be 
used as electron acceptor from glucose to form NADH and to continue energy 
production (GOODSELL, 2008). As mentioned before, “mellow” effects of polyenes also 
include the inhibition of glycolysis (PALACIOS & SERRANO, 1978), thus, the increased 
expression of LDH could possibly refer to that.  
 
Also remarkable was the poor expression of PFOR in general. This iron-sulfur protein 
is an enzyme in the hydrogenosomal metabolic pathway and oxidizes pyruvate to 
acetyl-CoA via reducing ferredoxin and releasing CO2. Ferredoxin transfers electrons 
to hydrogenase which converts H+ to H2 (MÜLLER, 1993). PFOR is assumed to be 
involved in the activation of metronidazole as reduced ferredoxin subsequently 
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reduces metronidazole to its nitroradical anion (MÜLLER, 1986). Furthermore, also a 
role of PFOR in resistance against metronidazole was proposed, due to its 
decreased or absent activity in resistant strains (KULDA, 1999).  
 
When iron is lacking, PFOR – which has a high uptake rate of iron – also shows 
diminished activity which might be a reason for its poor presence here (LEITSCH et al., 
2009). Stress caused by drug treatment may lead to a higher demand for iron for 
essential metabolic functions of the cell, thus lowering the activity of PFOR. This is 
also in agreement with the biological attribute of T. vaginalis responding to varying 
iron availability by mechanisms of differential gene expression (repression or 
overexpression of iron-depending enzymes to adapt itself to low nutrient supply) 
(GOMEZ et al., 2010). 
 
After cultivating trichomonads with additional iron supplement for four weeks, a 
stronger expression of PFOR was observable. The metronidazole-resistant strain 
(ATCC 30001) showed a remarkably increased susceptibility to metronidazole when 
incubated with additional iron. The novel, alternative mechanism of resistance 
assigns high-level metronidazole resistance to an absent thioredoxin reductase 
activity (LEITSCH et al., 2010). This finding supports the hypothesis of anaerobic 
metronidazole resistance which relies on a minimal PFOR activity (KULDA, 1999). It is 
also thinkable that true metronidazole resistance may be based not only on one 
single mechanism. This question still remains to be resolved, equally to the question 
of resistance to pentamycin.  
 
In the current study, the respective protein profiles of pentamycin-treated cells were 
rather the consequence of stress and harming effects caused by treatment and, to a 
certain extent, also due to manufactural differences between the 2D SDS-PAGE gels.  
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A final experiment was performed to investigate the role of LDH, and also to 
distinguish between wildtypes and R-strains that were treated 2h before and 48h 
before, respectively. Differences between these two approaches were expected to 
appear, in fact, all four gels were almost identical and no differences between any 
spot could be observed. Even LDH, that was stronger expressed in 50% of the 
previous analyses, appeared to be equally distinctive in all cases. Therefore, the 
hypothesis of a stronger expression of LDH in treated cells as well as an influence of 
drug administration shortly before harvesting could not be verified.  
 
Finally, long-term treatment during six months had no impact on the protein profile at 
all – although it cannot be excluded –, rather it may have been the consequence of 
inaccuracies in the 2D SDS-PAGE experimental procedure. The subsequent LDH 
activity assay supports this conclusion as no differences in the enzyme activity 
between wildtypes and R-strains could be detected. 
 
In summary, the majority of the identified proteins that were affected by long-term 
treatment are essential enzymes in metabolic pathways:  
 
Enolase catabolizes 2-phosphoglycerate to phosphoenolpyruvate which is an 
essential step in glycolysis. As low dose of pentamycin may inhibit glycolysis 
(PALACIOS & SERRANO, 1978), a fragmentation and impairment of enolase could refer 
to that.   
 
Actin, a structure protein, is essential in maintenance of the cytoskeleton. A 
degradation of actin may also affect the stability of the cell. Both cytosolic (cMDH) 
and hydrogenosomal malate dehydrogenase (hMDH) are responsible for catabolising 
malate to pyruvate, and especially hMDH is associated tightly with PFOR.  
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ADH1 belongs to the enzyme class of oxidoreductases, detoxifying alcohols to the 
respective aldehydes and ketones. An impairment of these proteins (and also the 
above mentioned LDH and PFOR) would obviously lead to malfunctions and 
damages of the cell.  
 
 
4.3.4  Mechanisms of adaption  
 
Although there were no significant differences in the protein profiles of untreated 
trichomonads and those after long-term treatment, differences in morphology and 
susceptibility to pentamycin were detectable. Adaption to pentamycin after six 
months of long-term treatment can be stated. In general, resistance to polyene 
antibiotics is rare and a build-up of a full established resistance can be a process of 
years (GHANNOUM & RICE, 1999).  
 
Knowledge in polyene resistance comes mainly from studies on fungi and ergosterol-
containing protozoa with amphotericin B, nystatin and also filipin. Exclusive 
resistance studies on pentamycin and cholesterol-containing protozoa have not been 
published yet, accordingly in this current study we were considering the hitherto 
reported equalities and similarities between the respective polyenes and of 
cholesterol- and ergosterol-containing organisms. 
 
In the 1970s, numerous studies have been published on the resistance to polyenes 
whereas a few should be cited here: To this date, resistance to polyenes did not 
present a serious problem, even after 15 years of polyene use and, as mentioned 
before, resistance did not occur except in few strains of Candida (HAMILTON-MILLER, 
1973).  
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From observations on laboratory produced S. cerevisiae-mutants resistant to nystatin 
it was proposed that zymosterol – a cholesterol intermediate – may have replaced 
ergosterol due to a defective production of ergosterol and accumulation of zymosterol 
in the cell membrane, which finally should prevent the drug from binding (THOMPSON 
et al., 1971). Furthermore, studies on polyene-resistance in Microsporum revealed 
that a lower susceptibility correlates with a decreased sterol content (CAPEK & SIMEK, 
1972). However, mutants lacking entirely ergosterol are very unlikely to develop in 
nature. 
 
Regarding the mechanism of drug resistance in general, there are two controversial 
theories: FRYBERG (1974) has suggested that “development of resistance occurs by 
selection of naturally occurring resistant cells, present in small numbers in the 
population” (GHANNOUM & RICE, 1999). Concerning polyenes, this would mean that 
sterols in these naturally resistant cells are modified so that the affinity for polyenes is 
reduced. In such populations these cells would replace the majority of non-resistant 
ones. On the contrary, ATHAR & WINNER (1971) have stated that resistance results 
rather from mutations – such as induced by drug treatment and consecutive 
differentiated gene expression as feedback mechanism – than from selection.  
 
Although many open questions remain, an explanation for the process of gradual 
adaption could also be a small naturally resistant population that spreads via lateral 
gene transfer (transformation, transduction) as well as partially altered sterol 
molecules that still allow a – hindered – polyene binding.  
 
Whether the basic mechanism may be selection or mutation, it can be stated for 
polyenes that the level of resistance is proportional to changes in the sterol content of 
the cell membrane, either qualitative or quantitative. According to  HAMILTON-MILLER 
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(1973), “resistant cells with altered sterol content should bind smaller amounts of 
polyene than do susceptible cells” (HAMILTON-MILLER, 1973).  
 
In case of Candida albicans, this phenomenon could be attributed to the total 
ergosterol content of the cell, replacement of some or all polyene-binding sterols by 
substitution of less-well binding sterols, e.g. by a 3-hydroxy or 3-oxo derivative, or 
reorientation or masking of ergosterol that changes sterically or thermodynamically 
dependent binding (GHANNOUM & RICE, 1999). A decrease in the ergosterol content to 
74–85% in C. albicans has been demonstrated (DICK et al., 1980) as well as a higher 
affinity of polyenes to ∆5,7- and ∆7-sterols than to ∆8-sterols (FRYBERG, 1974).  
 
Moreover, an amphotericin B-resistant strain of Cryptococcus neoformans showed a 
defect in ∆8,7-sterol isomerase, leading to accumulation of ergosta-5,8,22-dienol, 
ergosta-8,22-dienol, fecosterol and ergosta-8-enol, with a final depletion of ergosterol 
(KELLY et al., 1994). These findings fit to a previous study of 1974 in which Candida 
strains resistant to amphotericin B and nystatin were found to possess altered sterols 
with a lower affinity to polyenes. Especially a lack of ergosterol and ∆8,7-sterols was 
described (WOODS et al., 1974). 
 
MBONGO et al. (1998) have demonstrated that amphotericin B-resistant Leishmania 
donovani promastigotes show increased membrane fluidity and possess cholesta-
5,7,24-trien-3ß-ol (an ergosterol precursor) as major sterol in their membrane instead 
of ergosterol. Additionally, RAKOTOMANGA et al. (2005) have discovered that 
miltefosine-resistant Leishmania donovani promastigotes show alterations of their 
fatty acid and sterol metabolism, resulting in a lower membrane fluidity due to a lower 
amount of unsaturated phospholipid alkyl chains compared to those of wildtypes. 
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A similar mechanism would be plausible for the build-up of pentamycin resistance in 
T. vaginalis due to the reported alterations in the sterol metabolism and altered 
membrane cholesterol. 
 
The synthesis of cholesterol, from acetyl-CoA to precursor molecules like isoprenoids 
and squalenes, provides many possible ways for the cell to intervene in the action 
metabolism and forming sterol derivatives that lead to resistance. If truly resistant 
strains could be established, knock-out mutants of the candidate gene(s) could 
possibly show more knowledge of the mechanism of resistance.  
 
It was shown, that there is no cross resistance between amphotericin B and 
pentamycin, in contrast, these drugs seem to act synergistically. Cross resistance of 
metronidazole-resistant T. vaginalis to nitazoxanide, furazolidone, toyocamycin and 
2-fluoro-2’-deoxyadenosine has been described (WRIGHT et al., 2010) and cross 
resistance of amphotericin B-resistant Leishmania to azoles (although these drugs 
act differently to polyenes by inhibition of ergosterol biosynthesis) as well (OUELLETTE 
& WARD, 2003). Cross resistance of metronidazole to pentamycin seems unlikely due 
to the complete different mode of action, however, as amphotericin B is very similar 
to pentamycin, further research on the interaction of both drugs could be promising. 
In Leishmania and Trypanosoma inhibition of fatty acid and sterol biosynthesis and 
further depletion of membrane sterolscan be achieved by azole and triazole 
compounds (ROBERTS et al., 2003).  
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4.4   Relevance of temperature 
 
Lower temperatures did not only impair the motiltiy, vitality and reproducibility of 
trichomonads, but also seemed to make them less susceptible to pentamycin. The 
reversibility of this effect could be an evidence for a better affinity of pentamycin to 
the membrane of the parasite when it finds optimal living conditions.  
 
The function of sterols in the cell membrane is to keep up its integrity – which has 
been attributed to specialised microdomains called “lipid rafts” and caveolae that 
contain increased amounts of cholesterol (SIMONS & TOOMRE, 2000) – and also to 
increase its flexibility and fluidity over the range of physiological temperatures. At 
higher temperatures, cholesterol makes the membrane more rigid, impairing the 
motility of the phospholipids, while at lower temperatures it keeps up its fluidity.  
 
An altered membrane fluidity caused by non-lethal temperature changes could 
eventually impair the correct binding of pentamycin and cholesterol which could be 
recovered again at physiological temperature settings.  
 
 
 
4.5    Advantages of pentamycin as an antitrichomonal drug 
 
The results of this study show that pentamycin has the potential as a pharmaceutical 
drug against T. vaginalis. As mentioned before, the mode of action of pentamycin 
and the established drug metronidazole is entirely different. A previous, less pure 
preparation of pentamycin with a dose regimen of 3 mg daily up for 10 days or 6 mg 
daily up for 5 days (BALMER, 2009) shows a greater effectiveness and lower 
necessary application rate in vivo than metronidazole with a dosage regimen of 2 g 
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once or 250 mg three times daily for 7 days (CUDMORE et al., 2004). The MLC 
(minimal lethal concentration) after 24h for pentamycin was shown to be 1 µg/ml for 
all four included strains in this study. Compared to metronidazole, the metronidazole-
resistant strain (ATCC 50138) showed an MLC in vitro of 4 µg/ml (anaerobic) to 150 
µg/ml (aerobic) and the highly metronidazole-sensitive strain (ATCC 30001) showed 
an MLC in vitro of 0.5 µg/ml (anaerobic) to 2 µg/ml (aerobic) (MÜLLER & GORRELL, 
1983). Regarding this, pentamycin is four times more effective than metronidazole.  
 
Moreover, the increasing resistance of trichomonads against metronidazole – two 
different mechanisms have been described (KULDA, 1999; LEITSCH et al., 2010) – still 
remains a problem. In case of pentamycin, the situation looks different: As described 
for polyenes in general, resistance does hardly occur (HAMILTON-MILLER, 1973; 
GHANNOUM & RICE, 1999), further, in this current study it could also be shown that 
true resistance does not develop, not even after six months of permanent resistancy 
stress. However, we could show an adaption of T. vaginalis to low sublethal doses 
that was not hereditary and lost after stopping the treatment.  
 
Finally, the side effects of metronidazole, which is usually applied orally, can be 
severe to some extent (CUDMORE et al., 2004). Pentamycin was shown to be 
generally well-accepted with a few single cases of mild vaginal irritations (BALMER, 
2009; FREY TIRRI et al., 2010). Also, its chemical structure and high molecule weight 
makes it optimally applicable for a topical, intravaginal use (BALMER, 2009). 
 
Concluding, the results of this study suggest high suitability of pentamycin for 
pharmaceutical use in the treatment of trichomonosis. Clinical studies on its 
tolerability and application are underway.  
SUMMARY 
 143 
 
5   Summary 
 
In this study, the effect of pentamycin – a polyene antibiotic currently mainly used in 
the treatment of fungal infections – against the sexually transmitted human parasite 
Trichomonas vaginalis was examined. The three major aims were to investigate the 
molecular mode of action of the drug with focus on the protein composition of the cell; 
further to determine the relationship between applied drug dose and incubation time 
on four differently metronidazole-sensitive T. vaginalis strains; and finally to monitor 
the effects of long-term treatment and establishment of resistance. The investigated 
preparation of pentamycin has a purity grade of 94%. 
 
The primary methods that were used in this study include microscopy and staining 
techniques (Giemsa) to observe the effects of drug treatment in cell culture visually, 
and 1D and 2D SDS-PAGE to analyse the protein composition before and after the 
treatment. Further, it was worked with microtiter assays to determine the dose-effect 
relationship between pentamycin and trichomonads. Finally, statistic analyses were 
performed with Excel and SPSS. 
 
It could be shown that the mode of action of pentamycin is based on a binding to 
sterols of the cell membrane, leading to membrane instability and formation of pores. 
The effects vary from general cellular discomfort and rounded, spinning, and immotile 
cells at lower doses to severe structural damage, total lysis and cell death at higher 
doses. The proteome compared of treated and untreated cells has shown 
dramatically altered protein profiles which is attributed to the effluence of proteins out 
of the cell, which correlates positively with higher doses of pentamycin. 
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The general effect can be described as very fast and highly effective. One hour after 
treatment, an EC100 of 15 µg/ml and an EC50 of 2.2 µg/ml was significant, which is an 
remarkable low dose compared to metronidazole, the standard drug in treatment of 
trichomonosis. Moreover, all four investigated strains showed almost the same 
susceptibility to pentamycin, which makes pentaymcin applicable against 
metronidazole-resistant trichomonads.   
 
Six months of long-term treatment resulted in a reversible adaption of trichomonads 
to pentamycin, at which sensitivity turned out to be lower, especially at sublethal 
concentrations until 5 µg/ml. However, a dose of 15 µg/ml was still lethal. True 
resistance as well as cross resistance of pentmaycin to the polyene amphotericin B 
was not observable, moreover, a synergistic effect of both drugs could be shown.  
 
Protein profiles of adapted trichomonads was shown to be different from those of 
wildtypes and may have derived most probably from proteolysis and harming effects 
of long-term treatment with sublethal doses of pentamycin. An altered metabolism as 
a reason which might be an indication for resistance can be excluded.  
 
Altogether, this study confirms previous knowledge of antibiotics of the polyene group 
and reveals new insights in the mode of action of pentamycin against T. vaginalis. 
The results are promising for a pharmaceutical use of pentamycin in the medical 
treatment of trichomonosis. It showed a much lower incubation time, together with a 
higher efficacy and different action mechanism than metronidazole.  
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6   Appendix 
 
6.1 Glossary 
 
18S rRNA:  Part of the small eukaryotic ribosomal 40 S rRNA subunit (18S: 18 
Svedberg (10-13 seconds for sedimentation)), widely used in molecular analysis, 
especially for evolutionary history of invertebrates, due to its slow mutation rate.  
 
1D SDS-PAGE: A method to separate previously denatured proteins by their 
molecular mass as the negatively charged proteins migrate in an electric field to the 
positively charged anode. The proteins with a higher molecule mass migrate slower, 
whereas the proteins with lower molecule mass migrate faster. After they were 
stained, a specific pattern is visible and comparable with a standard marker. 
 
2D SDS-PAGE: This method separates proteins by their isoelectric point first 
(“isoelectric focusing”) whereas the proteins migrate until the pH where they are 
charged neutrally (“isoelectric point”) This is called the “first dimension” or “horizontal 
separation”. The “second dimension” or “vertical separation” is the same principle as 
the 1D SDS-PAGE. By this method, it is possible to identify proteins by their IEP and 
mass which is an advantage to 1D SDS-PAGE which does not allow to identify 
proteins with the same mass.  
 
Adenylate kinase: Catalizes the reaction 2 ADP ↔ ATP + AMP and plays therefore 
an important role in cellular energy homeostasis.  
 
Amphotericin B: Antifungal polyene drug, used also against leishmaniosis, primary  
amoebic meningoenzephalitis and trichomonosis.  
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Anaerobic: Organisms that do not require oxygen for their growth and may even die 
if oxygen is present (depending on obligate, facultative or aerotolerant anaerobic). 
 
Apoptosis: Programmed cell death with characteristic changes of the cell 
morphology, in contrary to necrosis. 
 
Bromophenol blue: 3',3",5',5"-tetrabromophenolsulfonphthalein, used as a dye and 
a pH indicator in electrophoresis. It makes the protein samples visible at their 
migration and indicates the pH which is also important for a successful analysis. 
 
Commensalism: Relationship between two organisms wherea one benefits but the 
other is not affected. 
 
Complementary DNA (cDNA): An synthesized DNA strand from an mRNA template 
catalized by the enzymes reverse transcriptase and DNA polymerase. It is often used 
to create a cDNA bank and to express eukaryotic genes in prokaryotes. Retroviruses 
also produce cDNA. 
 
Concentration: The relationship of a scientific unit to another, mostly larger unit; in 
this study the most frequently used concentration was µg/ml. 
 
Coomassie Brilliant Blue: Two similar triphenylmethane dyes (G-250 and R-250) 
that are used for staining proteins. Also referred as “Coomassie” only (named after 
the town Kumasi in Ghana). 
 
Cross resistance: Resistance to a usually toxic substance as a consequence of 
exposure to another, similar acting substance.  
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Cysteine proteinase: Polypeptide degrading enzymes with a common catalizing 
step that involves nucleophilic cysteine thiol. They play an ubiquitary role in 
physiology and development, such as growth, immune responses, and apoptosis. 
 
Cytochrome: A group of membrane-bound hemoproteins, responsible for electron 
transport.  
 
Cytostome: A part of the cell that features structures for ingestion (a sort of cell 
mouth).  
 
Dictyosome: Single stack of the Golgi apparatus.  
 
Dimethylsulfoxide (DMSO): (CH3)2SO, a polar atropic solvent, used here for 
dissolving and storage of pentamycin, amphotericin B and metronidazole. It also 
alleviates the penetration through the membrane in the target organism. 
 
Dose: The concentration related to the size of the organism, in this study it was the 
cell number; the most frequently used dose was µg/ml related to 106 cells. 
 
Dyspareunia: Painful sexual intercourse. 
 
Elongation factor (EF): Set of proteins that facilitate the connection of peptide bonds 
in the step of protein translation elongation. 
 
Effective concentration (EC): Concentration which leads to a distinct effect on an 
organism, in this case necrosis. The most important value is the EC50 – the 
concentration at which 50% of cells are vital – as it shows the comparably lowest 
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standard deviation. The other calculated value in this study was EC90, at which 90% 
of the cells are dead. 
 
Electrophoresis: The motion of dispersed charged particles in a fluid through a 
constant electric field, caused by the difference in charge of particle and surrounding 
fluid. Here, it is part of the SDS-PAGE technique.  
 
Endosymbiosis: Relationship between two organisms where one is living within the 
body or cell of the other and both benefit from each other. Examples are nitrogen-
fixing bacteria, and mitochondria and chloroplasts that are believed to be of 
prokaryotic origin. 
 
Enolase: Catalizes the conversion step of 2-phosphoglycerate (2-PG) to 
phosphoenolpyruvate (PEP) in glycolysis. Also known as phosphopyruvate 
dehydratase. 
 
Epigenetics: A field in genetics that focuses on changes in the phenotype and gene 
expressed caused by other mechanisms than changes in the underlying DNA 
sequence (Greek: epi: above, other). 
 
Equibrilation: The process in which a system has reached balance. In this study, 
equibrilation means  a step in 2D SDS-PAGE in which reduction of cysteine groups  
with dithiothreitol (DTT) and alkylation of reduced cysteines with iodacetamide (IAA) 
is required to obtain defined protein spots. 
 
Eukaryote: Cells with high organisation level, they contain nucleus with genetic 
material and other membrane-bound organelle like Golgi-apparatus, 
mitochondria,F.(Prokaryotes contain no nucleus and organelle, are more primitive 
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and usually smaller in size). 
 
Excavata: One of the six supergroups of the eukaryotes including Trichomonas. It 
contains multi-flagellated organisms with a characteristic cell mouth (cytostome). 
 
Glycocalyx: The outer layer on the cell membrane of eukaryotes and the cell wall of 
prokaryotes, consisting of polysaccharides bound covalently with glycoproteins and 
glycolipids. In prokaryotes it forms a cyst, providing protection from the environment 
whereas in eukaryotes it builds up a slime surface and also determines the blood 
group and rhesus factor.  
 
Glycolysis: The main step in the catabolizm of monosaccharides that involves the 
conversion from glycose to pyruvate. In further steps, pyruvate becomes catabolized 
to H2O and CO2 whereas the function is to obtain energy in form of ATP (“cellular 
respiration”). 
 
Golgi apparatus: A membrane-bound organella complex in eukaryotes that 
processes and packages macromolecules after their synthesis and before secretion.  
 
Heat shock proteins: An ubiquitary class of functionally related proteins whose 
expression is increased when cells are exposed to high temperatures and stress, 
protecting cellular proteins from denaturation.   
 
Heterotrophy: The property of organisms to need organic compounds as a carbon 
source (The opposite is autotrophy: The ability to fix carbon and organic compounds 
with energy from sunlight or inorganic compounds). 
 
Hydrogenase: Enzyme that catalizes the oxidation of hydrogen: H2 ↔ 2H
+ + 2e- 
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Hydrogenosomes: Cell organella in anaerobians that are analogues to mitochondria 
and function in cell respiration. It is believed that hydrogenosomes have secondary 
evolved from mitochondria as their host cells have adapted to anaerobic 
environments.  
 
Incidence: A term used in medical statistics. It means the number of new cases of an 
infection or a disease in a population group related to a certain time (usually 1 year). 
 
Inhibitory concentration (IC): Concentration which leads to a inhibitory effect 
(motility) on an organism. The most important value is the IC50 – the concentration at 
which 50% of cells are inhibited – as it shows the comparably lowest standard  
deviation. The other calculated value in this study was IC90, at which 90% of the cells 
are inhibited. 
 
Internal transcribed spacer (ITS): Sequence of non-functional rRNA between 
structural rRNAs sequences on a precursor script; shows a high degree of variation 
and is used studies that involve closely related species. 
 
Isoelectric focusing (IEF): A technqiue that allows to separate proteins by their 
different electric charges whereas the charge changes with the pH of the 
surroundings.  
 
Isoelectric point (IEP): The individual pH of value of a molecule where it is neutrally 
charged and stops to migrate in the electric field of the pH gradient of the IEF. 
 
Jaundice: Yellow pigmentation of the skin caused by increased levels of bilirubin in 
the blood, also known as Icterus. 
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Lactate dehydrogenase (LDH): A ubiquitary enzyme that catalizes the conversion 
from pyruvate to lactate in the cell respiration with simultaneous oxidation of NAD+ 
from NADH. It also plays an important role as marker for tissue or cell breakdown, 
f.e. necrosis leads to higher LDH levels.  
 
Leukocyte: White blood cell 
 
Lipophosphoglycan (LPG): The major glycoconjugate on the surface of T. vaginalis 
and important in pathogenesis. It is also found in Leishmania promastigotes where it 
promotes the protection of the parasite from the host’s immune responses. 
 
Macrolide: Group of drugs (mostly antibiotics) containing a macrocyclic lactone ring. 
 
Malate dehydrogenase (MDH): An enzyme in the citric acid cycle, converting malate 
into oxaloacetate. In T. vaginalis, there are isozymes in the cytosol and in the 
hydrogenosomes. MDH also supported the theory that hydrogenosomes may have a 
mitochondrial origin.  
 
Mastigont (also kinetid): A unit in flagellates, comprised of the flagella and their 
basal bodies, attached flagellar roots and associated centrosomal structures. 
 
Meiosis: Specialised cell division, necessary for sexual reproduction, localised in the 
primary sexual organ. A cell with a diploid set of chromosomes will be divided into 
four cells with a haploid set of chromosomes (gametes in animals, spores in fungi). 
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Messenger RNA (mRNA): The RNA transcript from a DNA template, providing the 
needed information for transcription into amino acids and finally proteins. The mRNA 
may underlie many modification and converting steps.  
 
Metronidazole: A 5-nitroimidazole drug, applied against bacteria and anerobic 
protozoa. 
 
Microaerophilic: Organisms that are actually anaerobians but tolerate or even grow 
best at little amounts of oxygen. 
 
Mitochondria: Cell organella in aerobic eukaryotes that are responsible for cell 
respiration. They are the analogue to the hydrogenosomes in anaerobians. 
 
Mitosis: The process of the division of the nucleus in eukaryotic cells. With the 
subsequently following cytokinesis or cell division that produces two daughter cells 
from one cell, it compasses the M-phase within the cell cycle. 
 
Monophyly: A term for a group (clade) of organisms that descend all from one 
common ancestor.  
 
Monoxenous: The property of a pathogenic organism to infect one host only.  
 
NAD: ferredoxin oxidoreductase: An enzyme that catalizes the reaction of reduced 
ferredoxin + NAD+ to oxidized ferredoxin + NADH + H+. 
 
Necrosis: The premature traumatic and death of cells, in contrary to apoptosis. 
 
Neutropenia: Abnormally low number of neutrophils (white blood cells) 
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Nile Red (9-diethylamino-5H-benzo [α] phenoxazine-5-one): Selective fluorescent 
lipophilic dye, produced by boiling of Nile Blue with sulfuric acid und used to visualize 
intracellular lipid droplets. Stained neutral lipids fluoresce yellow (590 nm), polar 
lipids fluoresce orange (600 nm). 
 
Nitroimidazole: Aromatic heterocyclic molecule (C3H4N2) with an additional 
nitrogroup.  
 
Nucleoside: Glycosylamines consisting of a nitrogenous bound to a ribose or 
desoxyribose, f.e. the nucleobases of DNA and RNA.  
 
Nucleotide: A nucleotide bound to one to three phosphate groups; the structural unti 
of DNA/RNA.  
 
Ortholog: Genes in different species that are related and originate from a common 
ancestor. 
 
Osmosis: The movement of water through a semi-permeable (biological) membrane 
from the area with low solute concentration to the area with high solute concentration 
with the purpose to reach equal solute concentration.  
 
Parabasalia: A class within the Excavata, described by Honigberg, 1973. 
Characteristics are their parabasal apparatus, anterior flagella cluster, anaerobic 
habitus and lack of mitochondria. 
 
Parasitism: A relationship between two organism whereas one benefits from the 
other without killing it. The parasite can be temporary or permanently, living in or on 
the mostly larger host. 
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Parasthesia: Loss of sensation (temporary or permanent) 
 
Polymerase Chain Reaction (PCR): A standard technique in molecular biology that 
allows to amplify DNA fragments millions of times, making them visible and 
identifyable. 
 
Pentamycin: A polyene macrolide antibiotic, obtained from Streptomyces pentaticus. 
It is used against fungal infections and trichomonosis. 
 
Peptidase (Protease): An enzyme that cleaves other proteins by hydrolysis of their 
peptide bonds.  
 
Phagocytosis: The process of ingestion of solid particles by the cell membrane and 
subsequent forming of a vesicle with the intaked particles in the cell. 
 
Pinocytosis: The process of ingestion of fluid particles by the cell membrane and 
subsequent forming of a vesicle with the intaked particles in the cell. 
 
Polyene: Chemical group of poly-unsaturated organic molecules with one or more   
alternating double and single carbon-carbon bonds.  
 
Polyploidy: The property of organisms to contain a set of more than two pairs of 
homologous chromosomes. 
 
Prevalence: A term used in medical statistics. It means the number of new cases of 
an infection or a disease divided by the number of individuals in the population. 
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Promastigotes: A morphological form of protozoan parasites f.e. Leishmania, 
Trypanosoma. It is the most common morphology in the insect host (mostly primary 
host). 
 
Protein: Organic macromolecule, assembled of linear arranged amino acids that are 
connected together by peptide bonds between the amino and carboxyl groups and 
are folded into a globular form. The organic tissue and cells of all organisms consist 
of proteins. A protein may also termed as gene product as it contains the information 
of one or more genes after mRNA processing and translation. 
 
Proteolysis: Degradation of proteins by peptidases or other factors. 
 
Proteome: The entire set of proteins in respective biological system (cell, tissue, or 
organism). 
 
Proteomics: The science of the function and structure of proteins.  
 
Purine: Aromatic heterocyclic molecule consisting of a pyrimidine connected with an 
imidazole ring f.e. guanine (G) and adenine (A) of the DNA, caffeine, uric acid. 
 
Pyrimidine: Aromatic heterocyclic molecule with two N-atoms at position 1 and 3 of 
the six-carbon ring, f.e. thymine (T) and cytosine (C) of the DNA. 
 
Pyruvate ferredoxin oxidoreductase (PFOR): Enzyme that catalizes the reaction 
pyruvate + CoA + 2 oxidized ferredoxin ↔ acetyl-CoA + CO2 + 2 reduced ferredoxin 
+ 2 H+ 
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Retinol binding protein 1 (RBP1): A carrier protein involved in the transport of 
retinol from the liver storage site to peripheral tissue. Encoded by the RBP1 gene. 
 
Resistance: Resistance against a drug is to ability of the organism to survive or to be 
more tolerant to highly toxic doses as a consequence of protective mechanisms 
developed by the organism. 
 
Ribosomal RNA (rRNA): A specific sort of RNA in the ribosomes and responsible for 
the protein manufacturing by providing peptidyl transferase activity.  
 
RNA interference (RNAi): A system in cells regulating the activity genes by small 
RNA molecules that bind to other RNAs.  
 
R-strain: A term used exclusively in this study for cell cultures of T. vaginalis that are 
exposed to sublethal drug treatment permanently with the aim to generate resistant 
trichomonads. 
 
Sensitivity: Percentage of true positive events (recall rate) 
 
Specificity: Percentage of true negative events 
 
Struma: Swelling in the thyroid gland; in humans it has medical importance whereas 
in birds it is part of their natural anatomy. 
 
Symbiosis: Relationship between two organisms where both benefit from each 
other. 
 
Thioredoxin reductase: Ubiquitary enzyme class that reduces thioredoxin by 
oxidation of NADPH; essential for cell growth and survival.  
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Transfer RNA (tRNA): The intermediate RNA molecule in transcription as it links 
each base triplet of the mRNA with a corresponding amino acid.  
 
Triosephosphate isomerase: An enzyme involvedin glycolysis as it catalizes the 
reversible interconversion of the triosephosphate isomers dihydroxyacetone 
phosphate and D-glyceraldehyde-3-phosphate. 
 
Valyl tRNA synthetase: An enzyme (ligase) that catalizes the reaction of ATP + L-
valine + tRNAVal ↔ AMP + Diphosphate + L-valyl-tRNAVal. It plays a major role in 
biosynthesis of the amino acids valine, leucine and isoleucine. 
 
 
6.2 Abbreviations 
 
1D SDS-PAGE: One dimensional sodium dodecylsulfate polyacrylamide 
gelelectrophoresis 
2D SDS-PAGE : Two dimensional sodium dodecylsulfate polyacrylamide 
gelelectrophoresis 
Acetyl-CoA: Acetyl coenzyme A 
ADH1 : Alcohol dehydrogenase 1 
ADP: Adenosine diphosphate 
AP: Adhesion protein 
APS: Ammoniumpersulfate 
ATCC: The Global Bioresource Center (www.atcc.org) 
ATP: Adenosine triphosphate 
CDF: Cell detaching factor 
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cDNA: complementary DNA 
CHAPS: 3-[(3-Cholamidopropyl) dimethylammonio]-propane- sulfonate 
cMDH: cytosolic malate dehydrogenase 
DMSO: Dimethylsulfoxide 
DNA: Desoxyribonucleic acid 
DTT: Dithiothreitol 
EC: Effective concentration 
EDTA: Ethylenediaminetetraacetic acid 
EF: elongation factor 
H+: hydrogen ion 
HIV: Human Immunodeficiency Virus 
IAA: Iodacetamide 
IC: Inhibitory concentration 
IEF: Isoelectric focusing 
IEP: Isoelectric point 
Ig: Immunoglobuline  
IPG: Immobilized pH gradient 
ITS: Internal transcribed spacer 
K+: potassium ion 
kbp: Kilo basepairs 
LDH: Lactate dehydrogenase 
LPG: Lipophosphoglycan 
MALDI-TOF: Matrix-assisted laser desorption/ionisation – time of flight 
Mb: megabases 
MIC: minimal inhibitory concentration 
MLC: minimal lethal concentration 
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MOPS: 3-N-morpholino-propanesulfonic acid 
mRNA: messenger RNA 
tRNA: transcription RNA  
NAD+: Nicotinamid adenine dinucleotide, oxidized form  
NADH: Nicotinamid adenine dinucleotide, reduced form  
NO2: nitrogen dioxide 
PBS: Phosphate buffered saline 
PCR: Polymerase Chain Reaction 
PFOR: Pyruvate ferredoxin oxidoreductase 
pH: pondus hydrogenii / potentia hydrogenii 
RBP1: Retinol binding protein 1 
rDNA: ribosomal DNA 
RNA: Ribonucleic acid 
RNAi: RNA interference 
rRNA: ribosomal RNA 
SM buffer: buffer containing sucrose and MOPS 
STD: Sexually Transmitted Disease 
TCA: Trichloroacetic acid 
TEMED: N, N, N’, N’ – tetramethylethylenediamine 
TYM: Trypticase Yeast Maltose 
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6.3  Chemical reagents 
 
The chemical reagents used in the experiments were obtained by the following 
companies:  
3-N-morpholino-propanesulfonic acid (Sigma), acetic acid (Merck), acetone (Merck),  
acrylamide (Sigma), ammoniumpersulfate (Sigma), amphotericin B, solubilized 
(Sigma), BioLyte 3-10 Buffer 100x (BioRad), BBL trypticase peptone: Pancreatic 
digest of casein (BD), Cell Freezing Medium-DMSO (Sigma), CHAPS minimum 98% 
TLC (SigmaUltra), Coomassie Brilliant Blue R-250 (Serva), Diamond Vitamin Tween 
80 Solution (40x) (Sigma), dimethylsulfoxide (Sigma), dipotassium-
hydrogenphosphate (Merck), DL-dithiothreitol (Sigma), ethanol (Merck), EDTA 
(Merck), glycine (Serva), glyercol (Merck), HCl (Merck), Horse serum heat-inactivated 
(Sigma), iodacetamide (Sigma), isopropanol (Merck), Giemsas azur-eosin-
methylenblue solution (Merck), L-ascorbic acid (Sigma), L-cysteine hydrochloride 
monohydrate (Merck),  maltose monohydrate (Merck), methanol (Merck), NADH 
(Sigma), NaOH (Merck), N,N,N’,N’,- tetramethylethylenediamine (Merck), penicillin G-
sodium 10 Mega IE (Sandoz), pentamycin (Carbogen Amcis), phosphate buffer 
solution after “Weise” (Sigma), potassiumdihydrogenphosphate (Merck), Prestained 
Protein Marker MW (PeqLab), pyruvate (Sigma), silver nitrate (Merck), sodium 
carbonate (Merck), Sodium dodecyl sulphate / SDS (Merck-Schuchardt), sodium 
thiosulfate (Merck),  sucrose (Sigma), thiourea (GE Healthcare), trichloroacetic acid 
(Sigma-Aldrich), Trizma base (Sigma), Tris-HCl (Sigma), Trypan blue solution, 0.4% 
in 0.81% sodium chloride and 0.06% potassium phosphate (Sigma), urea (Merck), 
water deionized, yeast extract (Merck) 
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6.4 Equipment 
 
Biorad 1D and 2D-gelelectrophoresis units, Eppendorf tubes 1.5 ml, Falcon 12.5 cm2 
tissue culture flasks, Fuchs-Rosenthal hemacytometer, GFR shaker, Heraeus 
incubator, Heraeus thermo centrifuge, Ikamag magnetic stirrer, Inolab 730 pH-
electrode, Jouan centrifuge, liquid nitrogen deep freezer, Nikon phase contrast 
microscope, Nunc 12- well and 24-well microtiter plates, Nunc cryopreservation 
tubes, Safe 2020 sterile bench, Sarstedt 50 ml tubes, standard chemicals, pipettes 
and tips, vacuum pump, - 85°C deep freezer 
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